FactSet Research Systems (FDS) 10-Q 3 Apr 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Feb. 29, 2024	Mar. 27, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Feb. 29, 2024
Document Transition Report	false
Entity File Number	1-11869
Entity Registrant Name	FACTSET RESEARCH SYSTEMS INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3362547
Entity Address, Address Line One	45 Glover Avenue
Entity Address, City or Town	Norwalk
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06850
City Area Code	203
Local Phone Number	810-1000
Title of 12(b) Security	Common Stock, $0.01 Par Value
Trading Symbol	FDS
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		38,115,834
Entity Central Index Key	0001013237
Current Fiscal Year End Date	--08-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false
New York Stock Exchange LLC
Entity Information [Line Items]
Security Exchange Name	NYSE
The Nasdaq Stock Market
Entity Information [Line Items]
Security Exchange Name	NASDAQ

Consolidated Statements of Inco

Consolidated Statements of Income - Unaudited - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Income Statement [Abstract]
Revenues	$ 545,945	$ 515,085	$ 1,088,161	$ 1,019,900
Operating expenses
Cost of services	255,142	240,806	506,763	467,848
Selling, general and administrative	108,807	104,582	209,518	210,178
Asset impairments	54	447	898	729
Total operating expenses	364,003	345,835	717,179	678,755
Operating income	181,942	169,250	370,982	341,145
Other income (expense), net
Interest income	2,847	2,903	5,859	5,108
Interest expense	(16,599)	(16,737)	(33,337)	(33,274)
Other income (expense), net	455	1,346	337	1,668
Total other income (expense), net	(13,297)	(12,488)	(27,141)	(26,498)
Income before income taxes	168,645	156,762	343,841	314,647
Provision for income taxes	27,705	25,169	54,346	46,256
Net income	$ 140,940	$ 131,593	$ 289,495	$ 268,391
Basic earnings per common share (in USD per share)	$ 3.70	$ 3.44	$ 7.61	$ 7.03
Diluted earnings per common share (in USD per share)	$ 3.65	$ 3.38	$ 7.49	$ 6.89
Basic weighted average common shares (in shares)	38,103	38,281	38,059	38,201
Diluted weighted average common shares (in shares)	38,650	38,981	38,646	38,947

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - Unaudited - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Statement of Comprehensive Income [Abstract]
Net income		$ 140,940	$ 131,593	$ 289,495	$ 268,391
Other comprehensive income (loss), net of tax
Net unrealized gain (loss) on cash flow hedges	[1]	(1,186)	(2,254)	(2,840)	4,301
Foreign currency translation adjustment gains (losses)		(2,956)	3,070	(1,048)	11,839
Other comprehensive income (loss)		(4,142)	816	(3,888)	16,140
Comprehensive income		$ 136,798	$ 132,409	$ 285,607	$ 284,531
[1]Presented net of a tax benefit of $419 thousand and $779 thousand for the three months ended February 29, 2024 and February 28, 2023, respectively. Presented net of a tax benefit of $1,007 thousand and a tax expense of $1,485 thousand for the six months ended February 29, 2024 and February 28, 2023, respectively.

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income - Unaudited (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Statement of Comprehensive Income [Abstract]
Net unrealized gain (loss) on cash flow hedges, tax (benefit) expense	$ (419)	$ (779)	$ (1,007)	$ 1,485

Consolidated Balance Sheets - U

Consolidated Balance Sheets - Unaudited - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
ASSETS
Cash and cash equivalents	$ 381,708	$ 425,444
Investments	68,519	32,210
Accounts receivable, net of reserves of $10,787 at February 29, 2024 and $7,769 at August 31, 2023	272,177	237,665
Prepaid taxes	42,570	24,206
Prepaid expenses and other current assets	58,047	50,610
Total current assets	823,021	770,135
Property, equipment and leasehold improvements, net	80,971	86,107
Goodwill	1,003,883	1,004,736
Intangible assets, net	1,860,609	1,859,202
Deferred taxes	24,345	27,229
Lease right-of-use assets, net	133,917	141,837
Other assets	64,120	73,676
TOTAL ASSETS	3,990,866	3,962,922
LIABILITIES
Accounts payable and accrued expenses	128,155	121,816
Current lease liabilities	28,965	28,839
Accrued compensation	72,319	112,892
Deferred revenues	175,121	152,430
Current taxes payable	17,832	31,009
Dividends payable	37,360	37,265
Total current liabilities	459,752	484,251
Long-term debt	1,489,488	1,612,700
Deferred taxes	8,232	6,737
Deferred revenues, non-current	3,177	3,734
Taxes payable	35,734	30,344
Long-term lease liabilities	185,759	198,382
Other liabilities	6,970	6,844
TOTAL LIABILITIES	2,189,112	2,342,992
Commitments and contingencies (see Note 11)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.01 par value, 10,000,000 shares authorized, none issued	0	0
Common stock, $0.01 par value; 150,000,000 shares authorized; 42,475,726 and 42,096,628 shares issued; 38,123,087 and 38,025,372 shares outstanding at February 29, 2024 and August 31, 2023, respectively	425	421
Additional paid-in capital	1,421,133	1,323,631
Treasury stock, at cost: 4,352,639 and 4,071,256 shares at February 29, 2024 and August 31, 2023, respectively	(1,248,707)	(1,122,077)
Retained earnings	1,719,932	1,505,096
Accumulated other comprehensive loss	(91,029)	(87,141)
TOTAL STOCKHOLDERS’ EQUITY	1,801,754	1,619,930
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 3,990,866	$ 3,962,922

Consolidated Balance Sheets -_2

Consolidated Balance Sheets - Unaudited (Parenthetical) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable reserve	$ 10,787	$ 7,769
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	42,475,726	42,096,628
Common stock, outstanding (in shares)	38,123,087	38,025,372
Treasury stock (in shares)	4,352,639	4,071,256

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - Unaudited - USD ($) $ in Thousands	6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 289,495	$ 268,391
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	58,650	52,208
Amortization of lease right-of-use assets	15,263	19,596
Stock-based compensation expense	30,962	27,500
Deferred income taxes	5,632	(6,470)
Asset impairments	898	729
Changes in assets and liabilities, net of effects of acquisitions
Accounts receivable, net of reserves	(39,468)	(54,294)
Accounts payable and accrued expenses	10,377	12,102
Accrued compensation	(40,456)	(51,714)
Deferred revenues	22,133	11,069
Taxes payable, net of prepaid taxes	(26,150)	(2,576)
Lease liabilities, net	(19,840)	(22,877)
Other, net	(8,554)	17,650
Net cash provided by operating activities	298,942	271,314
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, equipment, leasehold improvements and capitalized internal-use software	(38,383)	(35,416)
Purchases of investments	(44,936)	(10,889)
Net cash provided by (used in) investing activities	(83,319)	(46,305)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of debt	(125,000)	(250,000)
Dividend payments	(74,141)	(67,478)
Proceeds from employee stock plans	66,544	43,605
Repurchases of common stock	(112,165)	0
Other financing activities	(14,465)	(11,781)
Net cash provided by (used in) financing activities	(259,227)	(285,654)
Effect of exchange rate changes on cash and cash equivalents	(132)	2,698
Net increase (decrease) in cash and cash equivalents	(43,736)	(57,947)
Cash and cash equivalents at beginning of period	425,444	503,273
Cash and cash equivalents at end of period	$ 381,708	$ 445,326

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - Unaudited - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Aug. 31, 2022		41,653,218
Beginning balance at Aug. 31, 2022	$ 1,331,408	$ 417	$ 1,190,350	$ (930,715)	$ 1,179,739	$ (108,383)
Beginning balance, treasury stock (in shares) at Aug. 31, 2022				3,608,462
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	268,391				268,391
Other comprehensive income (loss)	16,140					16,140
Common stock issued for employee stock plans (in shares)		226,966		410
Common stock issued for employee stock plans	43,438	$ 2	43,602	$ (166)
Vesting of restricted stock (in shares)		69,699		27,303
Vesting of restricted stock	$ (11,614)	$ 1		$ (11,615)
Repurchase of common stock (in shares)	0
Repurchases of common stock	$ 0
Stock-based compensation expense	27,500		27,500
Dividends declared	(68,109)				(68,109)
Balance, end of period (in shares) at Feb. 28, 2023		41,949,883
Ending balance at Feb. 28, 2023	1,607,154	$ 420	1,261,452	$ (942,496)	1,380,021	(92,243)
Ending balance, treasury stock (in shares) at Feb. 28, 2023				3,636,175
Balance, beginning of period (in shares) at Nov. 30, 2022		41,848,430
Beginning balance at Nov. 30, 2022	1,474,128	$ 418	1,225,947	$ (941,705)	1,282,527	(93,059)
Beginning balance, treasury stock (in shares) at Nov. 30, 2022				3,634,322
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	131,593				131,593
Other comprehensive income (loss)	816					816
Common stock issued for employee stock plans (in shares)		95,543
Common stock issued for employee stock plans	20,181	$ 1	20,180
Vesting of restricted stock (in shares)		5,910		1,853
Vesting of restricted stock	$ (790)	$ 1		$ (791)
Repurchase of common stock (in shares)	0
Repurchases of common stock	$ 0
Stock-based compensation expense	15,325		15,325
Dividends declared	(34,099)				(34,099)
Balance, end of period (in shares) at Feb. 28, 2023		41,949,883
Ending balance at Feb. 28, 2023	$ 1,607,154	$ 420	1,261,452	$ (942,496)	1,380,021	(92,243)
Ending balance, treasury stock (in shares) at Feb. 28, 2023				3,636,175
Balance, beginning of period (in shares) at Aug. 31, 2023	38,025,372	42,096,628
Beginning balance at Aug. 31, 2023	$ 1,619,930	$ 421	1,323,631	$ (1,122,077)	1,505,096	(87,141)
Beginning balance, treasury stock (in shares) at Aug. 31, 2023	4,071,256			4,071,256
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 289,495				289,495
Other comprehensive income (loss)	(3,888)					(3,888)
Common stock issued for employee stock plans (in shares)		297,348		343
Common stock issued for employee stock plans	66,391	$ 3	66,541	$ (153)
Vesting of restricted stock (in shares)		81,750		32,040
Vesting of restricted stock	$ (14,312)	$ 1	(1)	$ (14,312)
Repurchase of common stock (in shares)	249,000			249,000
Repurchases of common stock	$ (112,165)			$ (112,165)
Stock-based compensation expense	30,962		30,962
Dividends declared	$ (74,659)				(74,659)
Balance, end of period (in shares) at Feb. 29, 2024	38,123,087	42,475,726
Ending balance at Feb. 29, 2024	$ 1,801,754	$ 425	1,421,133	$ (1,248,707)	1,719,932	(91,029)
Ending balance, treasury stock (in shares) at Feb. 29, 2024	4,352,639			4,352,639
Balance, beginning of period (in shares) at Nov. 30, 2023		42,297,330
Beginning balance at Nov. 30, 2023	$ 1,700,740	$ 423	1,366,343	$ (1,195,491)	1,616,352	(86,887)
Beginning balance, treasury stock (in shares) at Nov. 30, 2023				4,237,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	140,940				140,940
Other comprehensive income (loss)	(4,142)					(4,142)
Common stock issued for employee stock plans (in shares)		172,244		197
Common stock issued for employee stock plans	38,052	$ 2	38,138	$ (88)
Vesting of restricted stock (in shares)		6,152		1,802
Vesting of restricted stock	$ (873)			$ (873)
Repurchase of common stock (in shares)	113,050			113,050
Repurchases of common stock	$ (52,255)			$ (52,255)
Stock-based compensation expense	16,652		16,652
Dividends declared	$ (37,360)				(37,360)
Balance, end of period (in shares) at Feb. 29, 2024	38,123,087	42,475,726
Ending balance at Feb. 29, 2024	$ 1,801,754	$ 425	$ 1,421,133	$ (1,248,707)	$ 1,719,932	$ (91,029)
Ending balance, treasury stock (in shares) at Feb. 29, 2024	4,352,639			4,352,639

Description of Business

Description of Business	6 Months Ended
	Feb. 29, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	DESCRIPTION OF BUSINESS FactSet Research Systems Inc. and its wholly-owned subsidiaries (collectively, "we," "our," "us," the "Company" or "FactSet") is a global financial digital platform and enterprise solutions provider with open and flexible technologies that drive the investment community to see more, think bigger and do its best work. Our platform delivers expansive data, sophisticated analytics and flexible technology used by global financial professionals to power their critical investment workflows. As of February 29, 2024, we had more than 8,000 clients comprised of over 206,000 investment professionals, including institutional asset managers, bankers, wealth managers, asset owners, partners, hedge funds, corporate users and private equity and venture capital professionals. Our revenues are primarily derived from subscriptions to our multi-asset class data and solutions powered by our connected content, referred to as our "content refinery." Our products and services include workstations, portfolio analytics and enterprise solutions. We drive our business based on our detailed understanding of our clients' workflows, which helps us to solve their most complex challenges. We provide financial data and market intelligence on securities, companies, industries and people to enable our clients to research investment ideas, as well as to analyze, monitor and manage their portfolios. Our on- and off-platform solutions span the investment life cycle of investment research, portfolio construction and analysis, trade execution, performance measurement, risk management and reporting. We provide open and flexible technology offerings, including a configurable desktop and mobile platform, comprehensive data feeds, cloud-based digital solutions and application programming interfaces ("APIs"). Our CUSIP Global Services ("CGS") business supports security master files relied on by the investment industry for critical front, middle and back-office functions. Our platform and solutions are supported by our dedicated client service team. We operate our business through three reportable segments ("segments"): the Americas, EMEA and Asia Pacific. During fiscal 2024, we revised our internal organization within each segment to offer data, products and analytical applications by firm type: • "Institutional Buyside" focuses on asset managers, asset owners, and hedge fund companies, • "Dealmakers" focuses on banking and sell-side research, corporate, and private equity and venture capital workflows, • "Wealth" focuses on wealth management workflows, and • "Partnerships and CGS": "Partnerships" delivers solutions to content providers, financial exchanges, and rating agencies. "CGS" is the exclusive issuer of Committee on Uniform Security Identification Procedures ("CUSIP") and CUSIP International Number System ("CINS") identifiers. As our chief operating decision maker ("CODM") continues to review our business and operating results based on our three segments, the Americas, EMEA and Asia Pacific, the realignment of our internal organization by firm type will not impact our segments for fiscal 2024. Refer to Note 15, Segment Information , for further discussion on our segments and CODM.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation We conduct business globally and manage our business on a geographic basis. The accompanying unaudited Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all information and footnotes required by GAAP for annual financial statements. As such, the information in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023. The accompanying unaudited Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated. In the opinion of management, the accompanying unaudited Consolidated Financial Statements include all normal recurring adjustments, transactions or events discretely impacting the interim periods considered necessary to present fairly our results of operations, financial position, cash flows and equity. Reclassifications We presented the components of Interest expense, net separately as Interest income and Interest expense in the Consolidated Statements of Income for the three and six months ended February 29, 2024. We conformed the comparative figures for the three and six months ended February 28, 2023 to the current period presentation. Use of Estimates The preparation of our Consolidated Financial Statements and related disclosures in conformity with GAAP required management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates may include income taxes, stock-based compensation, goodwill and intangible assets, business combinations, long-lived assets, contingencies and impairment assessments. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of our assets and liabilities. Actual results could differ materially from those estimates. Concentrations of Credit Risk Credit risk arises from the potential nonperformance by counterparties to fulfill their financial obligations. Our financial instruments that potentially subject us to concentrations of credit risk consist primarily of our cash and cash equivalents, accounts receivable, investments in mutual funds and derivative instruments. The maximum credit exposure of our cash and cash equivalents, accounts receivable and investments in mutual funds is their carrying values as of the balance sheet date. The maximum credit exposure related to our derivative instruments is based upon their respective gross fair values as of the balance sheet date. Cash and Cash Equivalents and Investments We are exposed to credit risk on our cash, cash equivalents and investments in mutual funds in the event of default by the governmental and financial institutions with which we transact. We invest in a manner that aligns with our restrictive cash investment practices, preserves capital and provides liquidity, while minimizing our exposure to credit risk. We limit our exposure to credit loss by investing with multiple governmental and financial institutions that we believe are high-quality and credit-worthy. We have not experienced any credit losses relating to our cash, cash equivalents and investments in mutual funds. Accounts Receivable Our accounts receivable credit risk is dependent upon the financial stability of our individual clients. As of February 29, 2024 and August 31, 2023, our accounts receivable reserve was $10.8 million and $7.8 million, respectively. We do not require collateral from our clients; however, no single client represented more than 3.5% of our total revenues in any period presented. Our concentration of credit risk related to our accounts receivable is generally limited, due to our large and geographically dispersed client base. Derivative Instruments Our use of derivative instruments exposes us to credit risk to the extent counterparties may be unable to meet the terms of their agreements. To mitigate credit risk, we limit counterparties to financial institutions we believe are credit-worthy and use several institutions to reduce concentration risk. We do not expect any losses as a result of default by our counterparties. Concentrations of Data Providers We integrate data from various third-party sources into our hosted proprietary data and analytics platform. As certain data sources have a limited number of suppliers, we make every effort to assure that, where reasonable, alternative sources are available. We are not dependent on any individual third-party data supplier to meet the needs of our clients, with only two data suppliers each representing more than 10% of our total data costs for the six months ended February 29, 2024. Concentrations of Cloud Providers Our clients rely on us for the delivery of time-sensitive, up-to-date data and applications. Our business is dependent on our ability to process substantial volumes of data and transactions rapidly and efficiently. We currently use multiple providers of cloud services; however, one supplier provided the majority of our cloud computing support for the six months ended February 29, 2024. We maintain back-up facilities and other redundancies at our data centers, take security measures and have emergency planning procedures to minimize the risk that an event will disrupt our operations. Recently Adopted Accounting Pronouncements We did not adopt any new standards or updates issued by the Financial Accounting Standards Board ("FASB") during the three and six months ended February 29, 2024 that had a material impact on our Consolidated Financial Statements. Accounting Pronouncements Not Yet Adopted Income Taxes - Improvements to Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures . This ASU enhances annual income tax disclosures primarily related to our effective tax rate reconciliation and income taxes paid. The amendments in this ASU are to be applied prospectively, although retrospective application is permitted, and are effective for our annual financial statements starting in fiscal 2026. Early adoption is permitted. This ASU is not expected to have a material impact on our Consolidated Financial Statements. We are currently assessing the impact of the new requirements on our disclosures. Segment Reporting - Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures . This ASU enhances segment disclosures primarily related to significant segment expenses for both interim and annual periods. The amendments in this ASU are to be applied retrospectively and are effective for our annual financial statements starting in fiscal 2025 and interim periods starting in fiscal 2026. Early adoption is permitted. This ASU is not expected to have a material impact on our Consolidated Financial Statements. We are currently assessing the impact of the new requirements on our disclosures. Disclosure Improvements - Codification Amendment in Response to the Securities and Exchange Commission's ("SEC") Disclosure Update and Simplification Initiative In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements - Codification Amendment in Response to the SEC’s Disclosure Update and Simplification Initiative . The ASU incorporates several disclosure and presentation requirements currently residing in the SEC Regulations S-X and S-K. The amendments will be applied prospectively and are effective when the SEC removes the related requirements from Regulations S-X or S-K. Any amendments the SEC does not remove by June 30, 2027 will not be effective. As we are currently subject to these SEC requirements, this ASU is not expected to have a material impact on our Consolidated Financial Statements or related disclosures. No other new accounting pronouncements issued or effective as of February 29, 2024 have had, or are expected to have, a material impact on our Consolidated Financial Statements.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Feb. 29, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	REVENUE RECOGNITION We derive most of our revenues by providing client access to our multi-asset class solutions powered by our content refinery (referred to as the "Hosted Platform"). The Hosted Platform is a subscription-based service that provides client access to various combinations of products and services including workstations, portfolio analytics and enterprise solutions. We also derive revenues through our CGS platform, a subscription-based service that provides access to a database of universally recognized security identifiers and related descriptive data for issuers and their financial instruments (referred to as the "Identifier Platform"). The majority of each of our contracts with clients, whether for our Hosted Platform or Identifier Platform services, represents a single performance obligation covering a series of distinct products and services that are substantially the same and that have the same pattern of transfer to the client. The primary nature of the promise to the client is to provide daily access to each of these data and analytics platforms over the associated contractual term. These platforms provide integrated financial information, analytical applications and industry-leading service for the investment community. Based on the nature of the services and products offered by these platforms, we apply an output time-based measure of progress as the client is simultaneously receiving and consuming the benefits of the respective platform. We recognize revenue for the majority of these platforms in accordance with the 'as invoiced' practical expedient, because the consideration that we have the right to invoice corresponds directly with the value of our performance to date. There are no significant judgments that would impact the timing of revenue recognition. Due to our election of the practical expedient, we do not consider payment terms as a financing component within a client contract when, at contract inception, the period between the transfer of the promised services to the client and the payment timing for those services will be one year or less. The majority of client contracts have a duration of one year, or the amount we are entitled to receive corresponds directly with the value of our performance obligations completed to date. Therefore, we do not disclose the value of the remaining unsatisfied performance obligations. Disaggregated Revenues We disaggregate revenues from our client contracts by segment based on our clients' respective geographic locations. Our business segmentation by geography is aligned with the operational and economic characteristics of our business. Refer to Note 15, Segment Information , for further information. The following table presents revenues disaggregated by segment: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Americas $ 352,618 $ 331,121 $ 700,985 $ 654,488 EMEA 139,176 132,508 278,737 263,246 Asia Pacific 54,151 51,456 108,439 102,166 Total Revenues $ 545,945 $ 515,085 $ 1,088,161 $ 1,019,900

Fair Value Measures

Fair Value Measures	6 Months Ended
	Feb. 29, 2024
Fair Value Disclosures [Abstract]
Fair Value Measures	FAIR VALUE MEASURES Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date. In determining fair value, the use of various valuation methodologies, including market, income and cost approaches, are permissible. The inputs to these methodologies consider market comparable information, taking into account the principal or most advantageous market in which we would transact, when pricing the asset or liability. Fair Value Hierarchy The accounting guidance for fair value measurements establishes a three-level fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The hierarchy ranks the reliability of the inputs, based upon the lowest level of input that is significant to the fair value measurement, used to determine fair value. Our assessment of the significance of a particular input to the fair value measurement requires judgment and may affect its placement within the fair value hierarchy. We have categorized our assets and liabilities within the fair value hierarchy as follows: Level 1 – applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 – applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 – applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The assumptions used in determining fair value represent our best estimates, but these estimates involve inherent uncertainties and the application of our judgment. As a result, if factors change, our fair value estimates could be materially different in the future and may adversely affect our business and financial results. (a) Assets and Liabilities Measured at Fair Value on a Recurring Basis The following tables show, by level within the fair value hierarchy, our assets and liabilities that are measured at fair value on a recurring basis as of February 29, 2024, and August 31, 2023. We did not have any transfers between levels of fair value measurements during the six months ended February 29, 2024 and the fiscal year ended August 31, 2023. Fair Value Measurements as of February 29, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets Money market funds (1) $ 103,333 $ — $ — $ 103,333 Mutual funds (2) — 68,519 — 68,519 Derivative instruments (3) — 418 — 418 Total assets measured at fair value $ 103,333 $ 68,937 $ — $ 172,270 Liabilities Derivative instruments (3) $ — $ 490 $ — $ 490 Contingent Liability (4) — — 8,282 8,282 Total liabilities measured at fair value $ — $ 490 $ 8,282 $ 8,772 Fair Value Measurements as of August 31, 2023 (in thousands) Level 1 Level 2 Level 3 Total Assets Money market funds (1) $ 137,125 $ — $ — $ 137,125 Mutual funds (2) — 32,210 — 32,210 Derivative instruments (3) — 4,383 — 4,383 Total assets measured at fair value $ 137,125 $ 36,593 $ — $ 173,718 Liabilities Derivative instruments (3) $ — $ 608 $ — $ 608 Contingent Liability (4) — — 8,008 8,008 Total liabilities measured at fair value $ — $ 608 $ 8,008 $ 8,616 (1) Our money market funds are readily convertible into cash. The net asset value of each fund on the last day of the reporting period is used to determine its fair value. Our money market funds are included in Cash and cash equivalents within the Consolidated Balance Sheets. (2) Our mutual funds' fair value is based on the fair value of the underlying investments held by the mutual funds, allocated to each share of the mutual fund using a net asset value approach. The fair value of the underlying investments is based on observable inputs. Our mutual funds are included in Investments within the Consolidated Balance Sheets. (3) Our derivative instruments as of February 29, 2024 included our foreign exchange forward contracts and, as of August 31, 2023, included our foreign exchange forward contracts and our 2022 Swap Agreement. We utilize the income approach to measure fair value for our foreign exchange forward contracts. The income approach uses pricing models that rely on market observable inputs such as spot, forward and interest rates, as well as credit default swap spreads. To estimate fair value for our interest rate swap agreement, we utilize a present value of future cash flows, leveraging a model-derived valuation that uses observable inputs such as interest rate yield curves. Refer to Note 5, Derivative Instruments , for more information on our derivative instruments and their classification within the Consolidated Balance Sheets. (4) Our contingent liability resulted from the acquisition of a business during fiscal 2023. This liability reflects the present value of potential future payments that are contingent upon the achievement of certain specified milestones. The acquisition date fair value of the contingent liability was $7.9 million and was valued using a scenario-based method. This method incorporates unobservable inputs and assumptions made by management, including the probability of achieving specified milestones, expected time until payment and the discount rate. The fair value of the contingent liability is remeasured each reporting period until the contingency is resolved, with any changes in fair value recorded in Selling, general and administrative ("SG&A") within the Consolidated Statements of Income. The change in the fair value of the contingent liability from the acquisition date through February 29, 2024 was driven by the passage of time, with no changes made to key assumptions used in our fair value estimates. (b) Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis Assets that are measured at fair value on a non-recurring basis primarily include our property, equipment and leasehold improvements ("PPE"), lease right-of-use ("ROU") assets, goodwill and intangible assets. These assets are assessed for impairment whenever events or circumstances indicate their carrying value may not be fully recoverable, and at least annually for goodwill. The fair values of these non-financial assets are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparable information and discounted cash flow projections. (c) Assets and Liabilities Measured at Fair Value for Disclosure Purposes O nly We elected not to carry our Long-term debt on the Consolidated Balance Sheets at fair value. The carrying value of our Long-term debt is net of related unamortized discounts and debt issuance costs. Our Long-term debt is comprised of our Senior Notes and 2022 Credit Facilities. Our Senior Notes are publicly traded; therefore, the fair value of our Senior Notes is estimated based on quoted prices in active markets as of the reporting date, which are considered Level 1 inputs. The fair value of our 2022 Credit Facilities is estimated based on quoted market prices for similar instruments, adjusted for unobservable inputs to ensure comparability to our investment rating, maturity terms and principal outstanding, which are considered Level 3 inputs. Refer to Note 10, Debt for definitions of these terms and more information on the Senior Notes and 2022 Credit Facilities. The following table summarizes information on our outstanding debt as of February 29, 2024 and August 31, 2023: February 29, 2024 August 31, 2023 (in thousands) Fair Value Hierarchy Principal Amount Estimated Fair Value Principal Amount Estimated Fair Value 2027 Notes Level 1 $ 500,000 $ 465,950 $ 500,000 $ 460,890 2032 Notes Level 1 500,000 434,735 500,000 423,700 2022 Term Facility Level 3 250,000 251,093 375,000 376,406 2022 Revolving Facility Level 3 250,000 247,813 250,000 246,875 Total principal amount $ 1,500,000 $ 1,399,591 $ 1,625,000 $ 1,507,871 Total unamortized discounts and debt issuance costs (10,512) (12,300) Total net carrying value of debt $ 1,489,488 $ 1,612,700

Derivative Instruments

Derivative Instruments	6 Months Ended
	Feb. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	DERIVATIVE INSTRUMENTS Cash Flow Hedges In designing our hedging approach, we consider several factors, including offsetting exposures, the significance of exposures, the forecasting of risk and the potential effectiveness of the hedge to reduce the volatility of our earnings and cash flows. Factors considered in the decision to hedge an underlying market exposure include the materiality of the risk, the volatility of the market, the duration of the hedge, the degree to which the underlying exposure is committed, and the availability, effectiveness and cost of derivative instruments. Derivative instruments are only utilized for risk management purposes and are not used for speculative or trading purposes. We limit counterparties to financial institutions we believe are credit-worthy. Refer to Note 2, Summary of Significant Accounting Policies - Concentrations of Credit Risk , for further discussion on counterparty credit risk. We leverage foreign currency forward contracts and interest rate swap agreements to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates and to manage our floating interest rate exposure, respectively. For a derivative that was designated and qualified as a cash flow hedge, the effective portion of the change in fair value of the derivative is recorded in Accumulated Other Comprehensive Loss ("AOCL"), net of tax, in the Consolidated Balance Sheets. Realized gains or losses resulting from settlement of our foreign currency forward contracts and interest rate swap agreements are subsequently reclassified into SG&A and Interest expense, respectively, in the Consolidated Statements of Income when the hedges are settled. All of our derivatives qualified and were designated as cash flow hedges, and none of our derivatives were deemed ineffective, during the six months ended February 29, 2024 and February 28, 2023. There was no discontinuance of our cash flow hedges during the six months ended February 29, 2024 and February 28, 2023, and as such, no corresponding gains or losses related to changes in the value of our contracts were reclassified into earnings prior to settlement. Foreign Currency Forward Contracts As we operate globally, we are exposed to the risk that our financial condition, results of operations and cash flows could be impacted by changes in foreign currency exchange rates. As of February 29, 2024, we maintained a series of foreign currency forward contracts to hedge a portion of our primary currency exposures, namely the British Pound Sterling, Indian Rupee, Euro and Philippine Peso. We entered into these contracts with the intent to hedge between 25% to 75% of the currency exposure related to our projected operating income in these primary currencies over their respective hedge periods. The hedge maturity periods range from the third quarter of fiscal 2024 through the second quarter of fiscal 2025. The following table summarizes the gross notional value of our foreign currency forward contracts to purchase the respective local currency with U.S. dollars as of: February 29, 2024 August 31, 2023 (in thousands) Local Currency Amount Notional Contract Amount (USD) Local Currency Amount Notional Contract Amount (USD) British Pound Sterling £ 42,400 $ 53,431 £ 45,000 $ 56,098 Indian Rupee Rs 4,391,942 52,400 Rs 3,363,150 40,300 Euro € 43,700 47,960 € 39,000 42,646 Philippine Peso ₱ 1,890,330 33,600 ₱ 1,888,541 33,600 Total $ 187,391 $ 172,644 Refer to Part I, Item 3. Quantitative and Qualitative Disclosures About Market Risk of this Quarterly Report on Form 10-Q for further discussion of our exposure to foreign exchange rate fluctuations. Interest Rate Swap Agreements 2022 Swap Agreement On March 1, 2022, we entered into an interest rate swap agreement ("2022 Swap Agreement") with a notional amount of $800.0 million to hedge a portion of our outstanding floating Secured Overnight Financing Rate ("SOFR") debt with a fixed interest rate of 1.162%. The notional amount of the 2022 Swap Agreement declined by $100.0 million on a quarterly basis beginning May 31, 2022. Effective December 30, 2022, we partially novated our 2022 Swap Agreement to equally apportion the then outstanding notional amount of the interest rate swap between two counterparties. No other terms of the 2022 Swap Agreement were amended, terminated, or otherwise modified prior to its maturity. The 2022 Swap Agreement matured on February 28, 2024. 2024 Swap Agreement On March 1, 2024, we entered into an interest rate swap agreement ("2024 Swap Agreement") with a notional amount of $200.0 million to hedge a portion of our outstanding floating SOFR debt with a fixed interest rate of 5.145%. The notional amount of the 2024 Swap Agreement declines by $50.0 million on a quarterly basis beginning May 31, 2024 and matures on February 28, 2025. Refer to Note 10, Debt , for further discussion of our outstanding floating SOFR debt and refer to Part I, Item 3. Quantitative and Qualitative Disclosures About Market Risk of this Quarterly Report on Form 10-Q for further discussion of our exposure to interest rate risk on our long-term debt outstanding. Gross Notional Value and Fair Value of Derivative Instruments The following is a summary of the gross notional values of our derivative instruments: (in thousands) Gross Notional Value February 29, 2024 August 31, 2023 Foreign currency forward contracts $ 187,391 $ 172,644 Interest rate swap agreement — 200,000 Total cash flow hedges $ 187,391 $ 372,644 The following is a summary of the fair values of our derivative instruments: Fair Value of Derivative Instruments (in thousands) Derivative Assets Derivative Liabilities Derivatives designated as hedging instruments Balance Sheet Classification February 29, 2024 August 31, 2023 Balance Sheet Classification February 29, 2024 August 31, 2023 Foreign currency forward contracts Prepaid expenses and other current assets $ 418 $ 1,260 Accounts payable and accrued expenses $ 490 $ 608 Interest rate swap agreement Prepaid expenses and other current assets — 3,123 Accounts payable and accrued expenses — — Total cash flow hedges $ 418 $ 4,383 $ 490 $ 608 Derivative Recognition The following table provides the pre-tax effect of derivative instruments in cash flow hedging relationships for the three months ended February 29, 2024 and February 28, 2023: Gain (Loss) Recognized in AOCL on Derivatives Location of Gain (Loss) Reclassified from AOCL into Income Gain (Loss) Reclassified from AOCL into Income (in thousands) February 29, February 28, February 29, February 28, Derivatives in Cash Flow Hedging Relationships 2024 2023 2024 2023 Foreign currency forward contracts $ (623) $ (215) SG&A $ (47) $ (279) Interest rate swap agreement 17 848 Interest expense 1,046 3,945 Total cash flow hedges $ (606) $ 633 $ 999 $ 3,666 The following table provides the pre-tax effect of derivative instruments in cash flow hedging relationships for the six months ended February 29, 2024 and February 28, 2023: Gain (Loss) Reclassified in AOCL on Derivatives Location of Gain (Loss) Reclassified from AOCL into Income Gain (Loss) Reclassified from AOCL into Income (in thousands) February 29, February 28, February 29, February 28, Derivatives in Cash Flow Hedging Relationships 2024 2023 2024 2023 Foreign currency forward contracts $ (406) $ 3,108 SG&A $ 318 $ (5,244) Interest rate swap agreement 27 4,276 Interest expense 3,150 6,842 Total cash flow hedges $ (379) $ 7,384 $ 3,468 $ 1,598 As of February 29, 2024, we estimate that net pre-tax derivative losses of $0.1 million included in AOCL will be reclassified into earnings within the next 12 months. As of February 29, 2024, our cash flow hedges were highly effective with no amount of ineffectiveness recorded in the Consolidated Statements of Income. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. Offsetting of Derivative Instruments

Goodwill

Goodwill	6 Months Ended
	Feb. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	GOODWILL Changes in the carrying value of goodwill by segment for the six months ended February 29, 2024 are as follows: (in thousands) Americas EMEA Asia Pacific Total Balance at August 31, 2023 $ 704,759 $ 297,734 $ 2,243 $ 1,004,736 Acquisitions 181 — — 181 Foreign currency translations — (967) (67) (1,034) Balance at February 29, 2024 $ 704,940 $ 296,767 $ 2,176 $ 1,003,883 Goodwill is not amortized as it is estimated to have an indefinite life. Goodwill impairment is tested at the reporting unit level, which is consistent with our reportable segments. We test goodwill annually during the fourth quarter of each fiscal year or more frequently if events and circumstances occur indicating that it is more likely than not that the fair value of any one of our reporting units is less than its respective carrying value. If the carrying value of the reporting unit exceeds the fair value, then the goodwill is considered impaired and written down to the reporting unit’s fair value. We tested our goodwill for impairment during the fourth quarter of fiscal 2023 utilizing a quantitative analysis. We elected to bypass the optional qualitative assessment and concluded there was no impairment as the fair value of each of our reporting units exceeded its carrying value. Our goodwill impairment test performed during the fourth quarter of fiscal 2022 utilized a qualitative analysis and concluded there was no impairment as it was more likely than not that the fair value of each of our reporting units was not less than its respective carrying value.

Intangible Assets

Intangible Assets	6 Months Ended
	Feb. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS We amortize intangible assets on a straight line basis over their estimated useful lives. The following table presents the estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets as of February 29, 2024 and August 31, 2023: February 29, 2024 August 31, 2023 (in thousands, except useful lives) Estimated Useful Life (years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount ABA business process 36 $ 1,583,000 $ 87,944 $ 1,495,056 $ 1,583,000 $ 65,958 $ 1,517,042 Client relationships 11 to 26 265,129 74,416 190,713 265,315 68,701 196,614 Developed technology 3 to 5 145,213 45,901 99,312 109,222 45,560 63,662 Acquired databases 15 46,000 6,133 39,867 46,000 4,600 41,400 Software technology 2 to 10 142,368 112,798 29,570 142,395 108,702 33,693 Data content 7 to 20 35,169 29,320 5,849 35,021 28,508 6,513 Non-compete agreements 4 290 48 242 290 12 278 Total $ 2,217,169 $ 356,560 $ 1,860,609 $ 2,181,243 $ 322,041 $ 1,859,202 The weighted average useful life of our intangible assets as of February 29, 2024 was 32.1 years. Intangible assets are tested for impairment qualitatively on a quarterly basis or whenever events or changes in circumstances indicate that the carrying amount of an asset group is not recoverable. If indicators of impairment are present, our intangible assets are tested for impairment by comparing the carrying value to undiscounted cash flows and, if impaired, written down to fair value based on discounted cash flows. We did not identify a material impairment nor a material change to the estimated remaining useful lives of our intangible assets during the six months ended February 29, 2024 and February 28, 2023. Our intangible assets have no assigned residual values. The following table presents the amortization expense for our intangible assets which is included in Cost of services in our Consolidated Statements of Income: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Amortization expense $ 26,688 $ 21,782 $ 48,853 $ 43,436 As of February 29, 2024, estimated intangible asset amortization expense for each of the next five years and thereafter is as follows: (in thousands) Estimated Amortization Expense Years Ended August 31, 2024 (remaining six months) $ 53,369 2025 102,958 2026 95,323 2027 72,779 2028 63,279 Thereafter 1,472,901 Total $ 1,860,609

Income Taxes

Income Taxes	6 Months Ended
	Feb. 29, 2024
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES We are subject to taxation in the United States and various foreign jurisdictions in which we conduct our business. Income tax expense is based on taxable income determined in accordance with current enacted laws and tax rates. Deferred income taxes are recorded for the temporary differences between the financial statement carrying amounts and the tax basis of our assets and liabilities using currently enacted tax rates. Income Taxes Provision and Effective Tax Rate The provision for income taxes and the effective tax rate are as follows: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Income before income taxes $ 168,645 $ 156,762 $ 343,841 $ 314,647 Provision for income taxes $ 27,705 $ 25,169 $ 54,346 $ 46,256 Effective tax rate 16.4 % 16.1 % 15.8 % 14.7 % Our provision for income taxes for interim periods is calculated by applying an estimate of our annual effective tax rate to our quarter and year-to-date results, adjusted for discrete items recorded in the period. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pretax income (or loss) for the year, projections of the proportion of income (or loss) earned and taxed in foreign jurisdictions, permanent and temporary differences and the likelihood of recovering deferred tax assets, then adjusted for any discrete items. On a quarterly basis, we update the estimate of our annual effective tax rate as new events occur, assumptions change, or additional information is obtained. Our effective tax rate for the three and six months ended February 29, 2024 was lower than the applicable U.S. corporate income tax rate mainly due to a net tax benefit from the employee exercise of stock options, research and development ("R&D") tax credits and utilization of foreign tax credits, partially offset by our state taxes. For the three and six months ended February 28, 2023, our effective tax rate was lower than the applicable U.S. corporate income tax rate mainly due to R&D tax credits, a foreign derived intangible income ("FDII") deduction and a net tax benefit from the employee exercise of stock options. Our effective tax rate for the three months ended February 29, 2024 was higher than for the three months ended February 28, 2023, mainly driven by higher pretax income at applicable statutory tax rates and a higher overall foreign tax rate, partially offset by an increase in the exercise of stock options and increased utilization of foreign tax credits. Our effective tax rate for the six months ended February 29, 2024 was higher than for the six months ended February 28, 2023, mainly driven by higher pretax income at applicable statutory tax rates and a higher overall foreign tax rate, partially offset by increased utilization of foreign tax credits. Undistributed Foreign Earnings We permanently reinvest all foreign undistributed earnings, except in jurisdictions where earnings can be repatriated substantially free of tax. It is not practicable to determine the deferred tax liability that would be payable if these earnings were repatriated to the U.S. Inflation Reduction Act of 2022

Leases

Leases	6 Months Ended
	Feb. 29, 2024
Leases [Abstract]
Leases	LEASES Our lease portfolio is primarily related to our office space, under various operating lease agreements. We review new arrangements at inception to evaluate whether we obtain substantially all the economic benefits of and have the right to control the use of an asset. Our lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments at lease commencement (which includes fixed lease payments and certain qualifying index-based variable payments) over the reasonably certain lease term, leveraging an estimated incremental borrowing rate ("IBR") . Certain adjustments to calculate our lease ROU assets may be required due to prepayments, lease incentives received and initial direct costs incurred. We account for lease and non-lease components as a single lease component, which we recognize over the expected lease term on a straight-line expense basis in occupancy costs (a component of SG&A expense) in our Consolidated Statements of Income. As of February 29, 2024, we recognized $133.9 million of Lease ROU assets, net and $214.7 million of combined Current lease liabilities and Long-term lease liabilities in the Consolidated Balance Sheets. Our leases have a remaining lease term ranging from less than one year to just under 12 years and do not include any renewal or termination options that were not reasonably certain to be exercised. The following table presents our future minimum lease payments and a reconciliation to the combined Current lease liabilities and Long-term lease liabilities in the Consolidated Balance Sheets as of February 29, 2024 : (in thousands) Minimum Lease Years Ended August 31, 2024 (remaining six months) $ 19,037 2025 38,022 2026 37,658 2027 36,339 2028 31,771 Thereafter 88,843 Total minimum lease payments $ 251,670 Less: Imputed interest 36,946 Total lease liabilities $ 214,724 The following table includes components of our occupancy costs: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Operating lease costs (1) $ 7,645 $ 8,156 $ 15,263 $ 16,233 Variable lease costs (2) $ 4,817 $ 3,834 $ 9,306 $ 8,054 (1) Operating lease costs include costs associated with fixed lease payments and index-based variable payments that qualified for lease accounting under ASC 842, Leases and complied with the practical expedients and exceptions we elected. (2) Variable lease costs include costs that were not fixed at the lease commencement date and are not dependent on an index or rate. These costs were not included in the measurement of lease liabilities and primarily include variable non-lease costs, such as utilities, real estate taxes, insurance and maintenance, as well as lease costs for those leases that qualified for the short-term lease exception. The following table summarizes our weighted average remaining lease term and weighted average discount rate related to our operating leases recorded on the Consolidated Balance Sheets: As of February 29, 2024 As of August 31, 2023 Weighted average remaining lease term (in years) 7.4 7.8 Weighted average discount rate (IBR) 4.6 % 4.5 % The following table summarizes supplemental cash flow information related to our operating leases: Six Months Ended February 29, February 28, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities $ 19,811 $ 19,596 Lease ROU assets obtained in exchange for lease liabilities (1) $ 2,313 $ 1,379 Reductions to ROU assets resulting from reductions to lease liabilities (2) $ (23) $ — (1) Primarily includes new lease arrangements entered into during the respective period and contract modifications that extend our lease terms and/or provide additional rights. (2) Primarily relates to lease term reassessments based on contractual options to early terminate, resulting in a reduction to the lease liability and the corresponding lease ROU asset.

Debt

Debt	6 Months Ended
	Feb. 29, 2024
Debt Disclosure [Abstract]
Debt	DEBT We elected not to carry our Long-term debt at fair value. The carrying value of our debt is net of related unamortized discounts and debt issuance costs. Our total debt obligations as of February 29, 2024 and August 31, 2023 consisted of the following: (in thousands) Issuance Date Contractual February 29, 2024 August 31, 2023 2022 Credit Agreement 2022 Term Facility 3/1/2022 3/1/2025 $ 250,000 $ 375,000 2022 Revolving Facility 3/1/2022 3/1/2027 250,000 250,000 Senior Notes 2027 Notes 3/1/2022 3/1/2027 500,000 500,000 2032 Notes 3/1/2022 3/1/2032 500,000 500,000 Total unamortized discounts and debt issuance costs (10,512) (12,300) Total Long-term debt $ 1,489,488 $ 1,612,700 As of February 29, 2024, annual maturities on our total debt obligations, based on contractual maturity date, were as follows: (in thousands) Maturities Years Ended August 31, 2024 (remaining six months) $ — 2025 250,000 2026 — 2027 750,000 2028 — Thereafter 500,000 Total $ 1,500,000 2022 Credit Agreement On March 1, 2022, we entered into a credit agreement (the "2022 Credit Agreement") and borrowed an aggregate principal amount of $1.0 billion under its senior unsecured term loan credit facility (the "2022 Term Facility") and $250.0 million of the available $500.0 million under its senior unsecured revolving credit facility (the "2022 Revolving Facility" and, together with the 2022 Term Facility, the "2022 Credit Facilities"). The 2022 Term Facility matures on March 1, 2025, and the 2022 Revolving Facility matures on March 1, 2027. The 2022 Revolving Facility allows for the availability of up to $100.0 million in the form of letters of credit and up to $50.0 million in the form of swingline loans. We may seek additional commitments under the 2022 Revolving Facility from lenders or other financial institutions up to an aggregate principal amount of $750.0 million. We pay a commitment fee on the daily unused amount of the 2022 Revolving Facility using a pricing grid based on our senior unsecured non-credit enhanced long-term debt rating and our total leverage ratio. From the borrowing date through November 30, 2023, the commitment fee was 0.125%, which subsequently decreased to 0.1% through February 29, 2024. We used these borrowings, along with the net proceeds from the issuance of the Senior Notes (as defined below) and cash on hand, to finance the consideration for the CGS acquisition, to repay prior outstanding borrowings and to pay related transaction fees, costs and expenses. During fiscal 2022, we incurred approximately $9.5 million in debt issuance costs related to the 2022 Credit Facilities. Debt issuance costs are presented in the Consolidated Balance Sheets as a direct deduction from the carrying amount of the debt liability. Debt issuance costs are amortized to Interest expense in the Consolidated Statements of Income on a straight-line basis over the contractual term of the debt, which approximates the effective interest method. We may voluntarily prepay loans under the 2022 Credit Facilities at any time without premium or penalty. During the three and six months ended February 29, 2024, we repaid $62.5 million and $125.0 million, respectively, under the 2022 Term Facility, inclusive of voluntary prepayments of $50.0 million and $100.0 million, respectively. Since loan inception on March 1, 2022, we have repaid $750.0 million under the 2022 Term Facility, inclusive of voluntary prepayments of $662.5 million. From the borrowing date through November 30, 2023, the outstanding borrowings under the 2022 Credit Facilities bore interest at a rate equal to the applicable one-month Term SOFR plus a 1.1% spread (comprised of a 1.0% interest rate margin based on a debt leverage pricing grid plus a 0.1% credit spread adjustment). From December 1, 2023 through February 29, 2024, the spread decreased to 0.975% (comprised of a 0.875% interest rate margin based on a debt leverage pricing grid plus a 0.1% credit spread adjustment). Interest on the 2022 Credit Facilities is currently payable on the last business day of each month, in arrears. The 2022 Credit Agreement contains usual and customary event of default provisions for facilities of this type, which are subject to usual and customary grace periods and materiality thresholds. If an event of default occurs under the 2022 Credit Agreement, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings immediately due and payable. The 2022 Credit Agreement contains usual and customary affirmative and negative covenants for facilities of this type, including a financial covenant requiring maintenance of a total leverage ratio of no greater than 3.75 to 1.00 as of February 29, 2024. We were in compliance with all covenants and requirements of the 2022 Credit Agreement as of February 29, 2024. Swap Agreements 2022 Swap Agreement On March 1, 2022, we entered into the 2022 Swap Agreement to hedge a portion of our outstanding floating SOFR debt with a fixed interest rate of 1.162%. Effective December 30, 2022, we apportioned the then outstanding notional amount of the 2022 Swap Agreement between two counterparties. The 2022 Swap Agreement matured on February 28, 2024. 2024 Swap Agreement On March 1, 2024, we entered into the 2024 Swap Agreement to hedge a portion of our outstanding floating SOFR debt with a fixed interest rate of 5.145%. Refer to Note 5, Derivative Instruments for further discussion of the 2022 Swap Agreement and the 2024 Swap Agreement. Senior Notes On March 1, 2022, we completed a public offering of $500.0 million aggregate principal amount of 2.900% Senior Notes due March 1, 2027 (the "2027 Notes") and $500.0 million aggregate principal amount of 3.450% Senior Notes due March 1, 2032 (the "2032 Notes" and, together with the 2027 Notes, the "Senior Notes"). The Senior Notes were issued pursuant to an indenture, dated as of March 1, 2022, by and between us and U.S. Bank Trust Company, National Association, as trustee (the "Trustee"), as supplemented by the supplemental indenture, dated as of March 1, 2022, between us and the Trustee (the "Supplemental Indenture"). The Senior Notes were issued at an aggregate discount of $2.8 million and we incurred approximately $9.1 million in debt issuance costs. Debt discounts and debt issuance costs are presented in the Consolidated Balance Sheets as a net direct deduction from the carrying amount of the debt liability. The debt discounts and debt issuance costs are amortized to Interest expense in the Consolidated Statements of Income over the contractual term of the debt, leveraging the effective interest method. Interest on the Senior Notes is payable semiannually in arrears on March 1 and September 1 of each year. We may redeem the Senior Notes, in whole or in part, at any time at specified redemption prices, plus any accrued and unpaid interest. Upon the occurrence of a change of control triggering event (as defined in the Supplemental Indenture), we must offer to repurchase the Senior Notes at 101% of their principal amount, plus any accrued and unpaid interest. Interest Expense The following table presents the interest expense on our outstanding debt which is a component of Interest expense in our Consolidated Statements of Income: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Interest expense on outstanding debt (1) $ 16,589 $ 16,728 $ 33,318 $ 33,256 (1) Interest expense on our outstanding debt includes the related amortization of debt issuance costs and debt discounts, net of the effects of the 2022 Swap Agreement.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Feb. 29, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Commitments represent obligations, such as those for future purchases of goods or services, that are not yet recorded on the balance sheet as liabilities. We record liabilities for commitments when incurred (i.e., when the goods or services are received). We accrue non-income-tax liabilities for contingencies when we believe that a loss is probable, and the amount can be reasonably estimated. Judgment is required to determine both the probability and the estimated amount of loss. If the reasonable estimate of a probable loss is a range, we record the most probable estimate of the loss, or the minimum amount when no amount within the range is a better estimate than any other amount. We review accruals on a quarterly basis and adjust, as necessary, to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other current information. Contingent gains are recognized only when realized. Uncertain income tax positions are accounted for in accordance with applicable accounting guidance, refer to Note 10, Income Taxes in the Notes to the Consolidated Financial Statements included in Part II, Item 8. of our Annual Report on Form 10-K for the fiscal year ended August 31, 2023 for further details. Purchase Commitments with Suppliers and Vendors Purchase obligations represent our legally-binding agreements to purchase fixed or minimum quantities at determinable prices. As of August 31, 2023, we had total purchase obligations with suppliers of $362.2 million. Our total purchase obligations as of August 31, 2023 primarily related to hosting services, acquisition of data, and, to a lesser extent, third-party software providers. Hosting services support our hybrid cloud strategy, which relies in large part on third-party hosting providers. Data is an integral component of the value we provide to our clients. Our commitments to third-party software providers mainly include internal-use software licenses. For the six months ended February 29, 2024, there were no material changes to our purchase obligations. We also have contractual obligations related to our lease liabilities and outstanding debt. Refer to Note 9, Leases and Note 10, Debt for information regarding lease commitments and outstanding debt obligations, respectively. Capital Commitments As of February 29, 2024 and August 31, 2023, we had outstanding capital commitments related to an investment of $0.6 million and $0.7 million, respectively. Letters of Credit From time to time, we are required to obtain letters of credit in the ordinary course of business. As of February 29, 2024 and August 31, 2023, we had $0.5 million and $0.6 million of standby letters of credit outstanding, respectively. No liabilities related to these arrangements are reflected in the Consolidated Balance Sheets. Our 2022 Revolving Facility allows for the availability of up to $100.0 million in the form of letters of credit. We have not obtained any letters of credit under the 2022 Revolving Facility since its inception. Refer to Note 10, Debt, for information regarding the 2022 Revolving Facility. Contingencies Legal Matters We are engaged in various legal proceedings, claims and litigation that have arisen in the ordinary course of business. The outcome of all the matters against us are subject to future resolution, including the uncertainties of litigation. Based on information available at February 29, 2024, our management believes that the ultimate outcome of these unresolved matters against us, individually or in the aggregate, will not have a material adverse effect on our consolidated financial position, our results of operations or our cash flows. Income Taxes As a multinational company operating in many states and countries, we are routinely audited by various taxing authorities and have reserved for potential adjustments to our provision for income taxes that may result from examinations by, or any negotiated settlements with, these tax authorities. We believe that the final outcome of these examinations or settlements will not have a material effect on our consolidated financial position, results of operations or our cash flows. If events occur which indicate payment of these amounts is unnecessary, the reversal of the liabilities would result in the recognition of tax benefits in the period we determine the liabilities are no longer necessary. If our estimates of the federal, state and foreign income tax liabilities are less than the ultimate assessment, additional expense would result. Sales Tax Matters On August 8, 2019, we received a Notice of Intent to Assess (the "First Notice") additional sales taxes, interest and underpayment penalties (the "Sales Taxes") from the Commonwealth of Massachusetts Department of Revenue (the "Commonwealth") relating to the tax periods from January 1, 2006 through December 31, 2013. On July 20, 2021, we received a Notice of Intent to Assess (the "Second Notice") additional Sales Taxes from the Commonwealth relating to the tax periods from January 1, 2014 through December 31, 2018. On December 29, 2022, we received a Notice of Intent to Assess (the "Third Notice"; cumulatively with the First and Second Notices, the "Notices") additional Sales Taxes from the Commonwealth relating to the tax periods from January 1, 2019 through June 30, 2021. We requested pre-assessment conferences with the Department of Revenue's Office of Appeals to appeal the Notices, and on May 24, 2023, we received a Letter of Determination from the Commonwealth upholding the Notices, along with a Notice of Assessment for all the periods covered by the Notices. On June 22, 2023, we filed an Application for Abatement with the Commonwealth disputing all amounts assessed, which was subsequently denied. On February 20, 2024, we received a “Notice of Selection for Audit” for sales tax for the period from July 1, 2021 through December 31, 2023. We have filed petitions with the Appellate Tax Board to appeal all amounts assessed by the Commonwealth and believe that we will ultimately prevail; however, if we do not prevail, the amount of these assessments could have a material impact on our consolidated financial position, results of operations and cash flows. We have concluded that some payment to the Commonwealth is probable. We have recorded an accrual which is not material to our Consolidated Financial Statements. While we believe that the assumptions and estimates used to determine the accrual are reasonable, future developments could result in adjustments being made to this accrual. Indemnifications As permitted or required under Delaware law and to the maximum extent allowable under that law, we have certain obligations to indemnify each of our current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in, or not opposed to, the best interests of FactSet, and with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. It is not possible to determine the maximum potential amount for claims made under the indemnification obligations due to the unique set of facts and circumstances likely to be involved in each particular claim and indemnification provision; however, we have purchased a director and officer insurance policy that mitigates our exposure and may enable us to recover a portion of any future amounts paid. We do not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification obligations.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Feb. 29, 2024
Equity [Abstract]
Stockholders' Equity	STOCKHOLDERS' EQUITY Share Repurchases Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands, except share data) 2024 2023 2024 2023 Repurchases of common stock under the share repurchase program (1) 113,050 — 249,000 — Total cost of shares repurchased (1) $ 52,255 $ — $ 112,165 $ — (1) Amounts do not include repurchases of common stock primarily to satisfy tax withholding obligations due upon vesting of stock-based awards of 1,999 shares ($1.0 million) and 1,853 shares ($0.8 million) during the three months ended February 29, 2024 and February 28, 2023, respectively, and 32,383 shares ($14.5 million) and 27,713 shares ($11.8 million) during the six months ended February 29, 2024 and February 28, 2023, respectively. We may repurchase shares of our common stock under our share repurchase program from time-to-time in the open market or via privately negotiated transactions, subject to market conditions. We suspended our share repurchase program beginning in the second quarter of fiscal 2022 through the second quarter of fiscal 2023 to prioritize the repayment of debt under the 2022 Credit Facilities. As such, we did not repurchase any shares of our common stock under the share repurchase program during the three and six months ended February 28, 2023. There is no defined number of shares to be repurchased over a specified timeframe through the life of our share repurchase program. As of February 29, 2024, we had $187.8 million authorized under our share repurchase program for future share repurchases. Refer to Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds , of this Quarterly Report on Form 10-Q for further discussion on our share repurchase program. Equity-based Awards Refer to Note 14, Stock-Based Compensation for more information on equity awards issued during the three and six months ended February 29, 2024 and February 28, 2023. Dividends Our Board of Directors approved the following dividends: Year Ended Dividends per Record Date Total Amount (in thousands) Payment Date Fiscal 2024 First Quarter $ 0.98 November 30, 2023 $ 37,299 December 21, 2023 Second Quarter $ 0.98 February 29, 2024 $ 37,360 March 21, 2024 Fiscal 2023 First Quarter $ 0.89 November 30, 2022 $ 34,010 December 15, 2022 Second Quarter $ 0.89 February 28, 2023 $ 34,099 March 16, 2023 Future cash dividend payments will depend on our earnings, capital requirements, financial condition and other factors considered relevant by us and are subject to final determination by our Board of Directors. Accumulated Other Comprehensive Loss The components of AOCL as of February 29, 2024 and August 31, 2023 were as follows: (in thousands) February 29, 2024 August 31, 2023 Accumulated unrealized gains (losses) on cash flow hedges, net of tax $ 40 $ 2,880 Accumulated foreign currency translation adjustments (91,069) (90,021) Total AOCL $ (91,029) $ (87,141)

Earnings Per Share

Earnings Per Share	6 Months Ended
	Feb. 29, 2024
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE Basic earnings per common share ("Basic EPS") is computed by dividing net income by the number of weighted average common shares outstanding during the period. Diluted earnings per common share ("Diluted EPS") is computed using the treasury stock method, by dividing net income by the cumulative weighted average common shares that are outstanding or are issuable upon the exercise of outstanding stock-based compensation awards during the period. A reconciliation of the weighted average shares outstanding used in the Basic EPS and Diluted EPS computation is as follows: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands, except per share data) 2024 2023 2024 2023 Numerator Net income used for calculating Basic EPS and Diluted EPS $ 140,940 $ 131,593 $ 289,495 $ 268,391 Denominator Weighted average common shares used in the calculation of Basic EPS 38,103 38,281 38,059 38,201 Common stock equivalents associated with stock-based compensation plan 547 700 587 746 Shares used in the calculation of Diluted EPS 38,650 38,981 38,646 38,947 Basic EPS $ 3.70 $ 3.44 $ 7.61 $ 7.03 Diluted EPS $ 3.65 $ 3.38 $ 7.49 $ 6.89 Stock options that were out-of-the-money and performance share units ("PSUs") in which the performance criteria have not been met as of the end of the respective reporting period are omitted from the calculation of Diluted EPS as their impact was antidilutive. The following table presents those awards that were excluded from Diluted EPS for the periods presented: As of February 29, As of February 28, (in thousands) 2024 2023 Out-of-the-money stock options 0 543 PSUs 95 93

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Feb. 29, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	STOCK-BASED COMPENSATION Our stock-based awards include stock options, restricted stock units ("RSUs"), PSUs and common stock purchased by eligible employees under our employee stock purchase plan ("ESPP"). We measure and recognize stock-based compensation for all stock-based awards granted to our employees and our non-employee members of the Board of Directors ("non-employee directors") based on their estimated grant date fair value. To estimate the grant date fair value, we utilize a lattice-binomial option-pricing model ("binomial model") for our employee stock options and the Black-Scholes model for non-employee director stock options and common stock purchased by eligible employees under our ESPP. For RSUs and PSUs (collectively, "Restricted Stock Awards"), the grant date fair value is measured by reducing the grant date price of our common stock by the present value of future dividend payments on the underlying stock during the requisite service period. The number of PSUs granted assumes target-level achievement of the specified performance levels within the payout range. The ultimate number of common shares that may be earned from a PSU is determined based on the actual achievement of the specified performance levels within the payout range. Stock-based compensation expense for stock option and RSU awards is recognized over the requisite service period using the straight-line method. For granted stock options and RSUs, the amount of stock-based compensation expense recognized on any date is at least equal to the vested portion of the award on that date. Our PSUs require us to make assumptions regarding the probability of achieving specified performance levels established at the time of grant and we recognize stock-based compensation expense using the straight-line method over the requisite service period. The probability of achieving the specified performance levels is reviewed on a quarterly basis to ensure the amount of stock-based compensation expense appropriately reflects the expected achievement. The ultimate number of common shares that may be earned pursuant to these PSU awards range from 0% to 150% of the number of target shares for the November 2022 annual grant and 0% to 200% of the number of target shares for the November 2023 annual grant, depending on the level of our achievement of stated financial performance objectives. For our ESPP, stock-based compensation expense is recognized on a straight-line basis over the offering period. Stock-based awards are subject to the continued employment and continued service at the time of vesting by employees and non-employee directors, respectively. Compensation expense for stock-based awards is recorded net of estimated forfeitures, which are based on historical forfeiture rates and are revised if actual forfeitures differ from those estimates. The following table presents the stock-based compensation for the periods presented: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Stock-based compensation expense $ 16,652 $ 15,325 $ 30,962 $ 27,500 There were no stock-based compensation costs capitalized in any periods presented. As of February 29, 2024, $151.8 million of total unrecognized compensation expense related to non-vested stock-based awards is expected to be recognized over a weighted average vesting period of 3.1 years. As of February 29, 2024, we had 3.7 million employee stock-based awards available for grant under the FactSet Research Systems Inc. Stock Option and Award Plan, as Amended and Restated (the "LTIP"). Employee Stock Option Awards Our annual employee stock option grant, made during the first quarter of each fiscal year, makes up the majority of our stock options granted under the LTIP in each fiscal year. The following table presents the employee stock options granted under the LTIP for the six months ended February 29, 2024 and February 28, 2023: Six Months Ended February 29, February 28, 2024 2023 Stock options granted (1) 243,125 267,641 Weighted average exercise price $ 436.63 $ 426.25 Weighted average grant date fair value $ 132.60 $ 125.58 (1) Includes the annual employee grant on November 1, 2023 and November 1, 2022 of 242,371 and 266,051 stock options, respectively. These annual employee grants both vest 20% annually on the anniversary date of the grant and are fully vested after five years, expiring ten years from the date of grant. As part of the November 1, 2023 annual employee grant, the estimated grant date fair value, using the binomial model, leveraged the following assumptions: November 1, 2023 Annual Employee Grant Details Risk-free interest rate 4.78% - 5.53% Expected life (years) 6.62 Expected volatility 23.5% Dividend yield 0.90% Estimated fair value $132.60 Exercise price $436.57 Employee Restricted Stock Awards Restricted Stock Awards are granted to our employees under the LTIP. These awards entitle the holders to shares of common stock as the Restricted Stock Awards vest, but not to dividends declared on the underlying shares while the stock subject to the Restricted Stock Awards is unvested. Our Restricted Stock Awards granted during the six months ended February 29, 2024 and February 28, 2023, primarily related to our annual grants on November 1, 2023 and November 1, 2022, respectively, and were as follows: Six Months Ended February 29, February 28, 2024 2023 Shares Weighted Average Grant Date Fair Value Per Award Shares Weighted Average Grant Date Fair Value Per Award RSUs Granted (1) 64,827 $ 425.09 47,371 $ 415.33 PSUs Granted (2) 37,008 $ 424.63 34,482 $ 415.31 Performance adjustment - PSUs (3) 14,472 $ 306.33 8,542 $ 245.67 Total Restricted Stock Awards 116,307 90,395 (1) The majority of the RSUs granted vest 20% annually on the anniversary date of the grant and are fully vested after five years. (2) The majority of the PSUs granted cliff vest on the third anniversary of the grant date, subject to the achievement of certain performance metrics. The ultimate number of common shares that may be earned pursuant to these PSU awards range from 0% to 150% of the number of target shares for the November 2022 annual grant and 0% to 200% of the number of target shares for the November 2023 annual grant, depending on the level of our achievement of stated financial performance objectives. (3) For the three months ended February 29, 2024 and February 28, 2023, additional PSUs were granted based on performance above the specified target level of achievement for PSUs granted on November 9, 2020 and November 1, 2019, respectively. Employee Stock Purchase Plan Shares of FactSet common stock may be purchased by eligible employees under our ESPP in three-month intervals. The purchase price is equal to 85% of the lesser of the fair market value of our common stock on the first day or the last day of each three-month offering period. Employee purchases may not exceed 10% of their gross compensation, and there is a $25,000 contribution limit per employee for each calendar year. Shares purchased through our ESPP cannot be sold or otherwise transferred for 18 months after purchase. Dividends paid on shares held in our ESPP are used to purchase additional ESPP shares at the market price on the dividend payment date. Stock-based compensation expense related to our ESPP was $0.6 million for both the three months ended February 29, 2024 and February 28, 2023. Stock-based compensation expense related to our ESPP was $1.2 million for the six months ended February 29, 2024 and $1.3 million for the six months ended February 28, 2023. As of February 29, 2024, our ESPP had 45,503 shares reserved for future issuance.

Segment Information

Segment Information	6 Months Ended
	Feb. 29, 2024
Segment Reporting [Abstract]
Segment Information	SEGMENT INFORMATION Operating segments are defined as components of an enterprise that have the following characteristics: (i) they engage in business activities from which they may earn revenue and incur expense, (ii) their operating results are regularly reviewed by the CODM for resource allocation decisions and performance assessment, and (iii) their discrete financial information is available. Our Chief Executive Officer functions as our CODM. We have three operating segments: Americas, EMEA and Asia Pacific. This is how our CODM manages our business and the geographic markets in which we operate. These operating segments are consistent with our reportable segments. The Americas segment serves our clients throughout North, Central, and South America. The EMEA segment serves our clients in Europe, the Middle East, and Africa. The Asia Pacific segment serves our clients in Asia and Australasia. Segment revenues reflect sales to our clients based on their respective geographic locations. Each segment records expenses related to its individual operations with the exception of expenditures associated with our data centers, third-party data costs and corporate headquarters charges, which are recorded by the Americas segment and are not allocated to the other segments. The expenses incurred at our content collection centers, located in India, the Philippines and Latvia, are allocated to each segment based on their respective percentage of revenues as this reflects the benefits provided by each segment. The following tables reflect the results of operations of our segments: (in thousands) Americas EMEA Asia Pacific Total For the three months ended February 29, 2024 Revenues $ 352,618 $ 139,176 $ 54,151 $ 545,945 Operating income $ 81,711 $ 62,839 $ 37,392 $ 181,942 Capital expenditures (1) $ 20,015 $ 295 $ 1,607 $ 21,917 (in thousands) Americas EMEA Asia Pacific Total For the three months ended February 28, 2023 Revenues $ 331,121 $ 132,508 $ 51,456 $ 515,085 Operating income $ 61,181 $ 68,941 $ 39,128 $ 169,250 Capital expenditures (1) $ 15,589 $ 739 $ 1,128 $ 17,456 (in thousands) For the six months ended February 29, 2024 Americas EMEA Asia Pacific Total Revenues $ 700,985 $ 278,737 $ 108,439 $ 1,088,161 Operating income $ 162,559 $ 131,704 $ 76,719 $ 370,982 Capital expenditures (1) $ 34,793 $ 1,256 $ 2,334 $ 38,383 (in thousands) For the six months ended February 28, 2023 Americas EMEA Asia Pacific Total Revenues $ 654,488 $ 263,246 $ 102,166 $ 1,019,900 Operating income $ 128,712 $ 136,263 $ 76,170 $ 341,145 Capital expenditures (1) $ 31,343 $ 1,312 $ 2,761 $ 35,416 (1) Capital expenditures includes purchases of property, equipment and leasehold improvements and capitalized internal-use software. Segment Total Assets The following table reflects the total assets for our segments as of: (in thousands) February 29, 2024 August 31, 2023 Segment Assets Americas $ 3,121,172 $ 3,148,192 EMEA 605,954 558,393 Asia Pacific 263,740 256,337 Total assets $ 3,990,866 $ 3,962,922

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Pay vs Performance Disclosure
Net income	$ 140,940	$ 131,593	$ 289,495	$ 268,391

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Feb. 29, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Feb. 29, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation We conduct business globally and manage our business on a geographic basis. The accompanying unaudited Consolidated Financial Statements and Notes to the Consolidated Financial Statements included in this Quarterly Report on Form 10-Q are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all information and footnotes required by GAAP for annual financial statements. As such, the information in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023. The accompanying unaudited Consolidated Financial Statements include our accounts and those of our wholly-owned subsidiaries; all intercompany activity and balances have been eliminated.
Reclassifications	Reclassifications
Use of Estimates	Use of Estimates The preparation of our Consolidated Financial Statements and related disclosures in conformity with GAAP required management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates may include income taxes, stock-based compensation, goodwill and intangible assets, business combinations, long-lived assets, contingencies and impairment assessments. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of our assets and liabilities. Actual results could differ materially from those estimates.
Concentrations of Credit Risk, Data Providers and Cloud Providers	Concentrations of Credit Risk Credit risk arises from the potential nonperformance by counterparties to fulfill their financial obligations. Our financial instruments that potentially subject us to concentrations of credit risk consist primarily of our cash and cash equivalents, accounts receivable, investments in mutual funds and derivative instruments. The maximum credit exposure of our cash and cash equivalents, accounts receivable and investments in mutual funds is their carrying values as of the balance sheet date. The maximum credit exposure related to our derivative instruments is based upon their respective gross fair values as of the balance sheet date. Cash and Cash Equivalents and Investments We are exposed to credit risk on our cash, cash equivalents and investments in mutual funds in the event of default by the governmental and financial institutions with which we transact. We invest in a manner that aligns with our restrictive cash investment practices, preserves capital and provides liquidity, while minimizing our exposure to credit risk. We limit our exposure to credit loss by investing with multiple governmental and financial institutions that we believe are high-quality and credit-worthy. We have not experienced any credit losses relating to our cash, cash equivalents and investments in mutual funds. Accounts Receivable Our accounts receivable credit risk is dependent upon the financial stability of our individual clients. As of February 29, 2024 and August 31, 2023, our accounts receivable reserve was $10.8 million and $7.8 million, respectively. We do not require collateral from our clients; however, no single client represented more than 3.5% of our total revenues in any period presented. Our concentration of credit risk related to our accounts receivable is generally limited, due to our large and geographically dispersed client base. Derivative Instruments Our use of derivative instruments exposes us to credit risk to the extent counterparties may be unable to meet the terms of their agreements. To mitigate credit risk, we limit counterparties to financial institutions we believe are credit-worthy and use several institutions to reduce concentration risk. We do not expect any losses as a result of default by our counterparties. Concentrations of Data Providers We integrate data from various third-party sources into our hosted proprietary data and analytics platform. As certain data sources have a limited number of suppliers, we make every effort to assure that, where reasonable, alternative sources are available. We are not dependent on any individual third-party data supplier to meet the needs of our clients, with only two data suppliers each representing more than 10% of our total data costs for the six months ended February 29, 2024. Concentrations of Cloud Providers
Recently Adopted Accounting Pronouncements and Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements We did not adopt any new standards or updates issued by the Financial Accounting Standards Board ("FASB") during the three and six months ended February 29, 2024 that had a material impact on our Consolidated Financial Statements. Accounting Pronouncements Not Yet Adopted Income Taxes - Improvements to Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures . This ASU enhances annual income tax disclosures primarily related to our effective tax rate reconciliation and income taxes paid. The amendments in this ASU are to be applied prospectively, although retrospective application is permitted, and are effective for our annual financial statements starting in fiscal 2026. Early adoption is permitted. This ASU is not expected to have a material impact on our Consolidated Financial Statements. We are currently assessing the impact of the new requirements on our disclosures. Segment Reporting - Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures . This ASU enhances segment disclosures primarily related to significant segment expenses for both interim and annual periods. The amendments in this ASU are to be applied retrospectively and are effective for our annual financial statements starting in fiscal 2025 and interim periods starting in fiscal 2026. Early adoption is permitted. This ASU is not expected to have a material impact on our Consolidated Financial Statements. We are currently assessing the impact of the new requirements on our disclosures. Disclosure Improvements - Codification Amendment in Response to the Securities and Exchange Commission's ("SEC") Disclosure Update and Simplification Initiative In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements - Codification Amendment in Response to the SEC’s Disclosure Update and Simplification Initiative . The ASU incorporates several disclosure and presentation requirements currently residing in the SEC Regulations S-X and S-K. The amendments will be applied prospectively and are effective when the SEC removes the related requirements from Regulations S-X or S-K. Any amendments the SEC does not remove by June 30, 2027 will not be effective. As we are currently subject to these SEC requirements, this ASU is not expected to have a material impact on our Consolidated Financial Statements or related disclosures. No other new accounting pronouncements issued or effective as of February 29, 2024 have had, or are expected to have, a material impact on our Consolidated Financial Statements.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Feb. 29, 2024
Revenue from Contract with Customer [Abstract]
Schedule of disaggregation of revenue	The following table presents revenues disaggregated by segment: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Americas $ 352,618 $ 331,121 $ 700,985 $ 654,488 EMEA 139,176 132,508 278,737 263,246 Asia Pacific 54,151 51,456 108,439 102,166 Total Revenues $ 545,945 $ 515,085 $ 1,088,161 $ 1,019,900

Fair Value Measures (Tables)

Fair Value Measures (Tables)	6 Months Ended
	Feb. 29, 2024
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities measured at fair value on a recurring basis	The following tables show, by level within the fair value hierarchy, our assets and liabilities that are measured at fair value on a recurring basis as of February 29, 2024, and August 31, 2023. We did not have any transfers between levels of fair value measurements during the six months ended February 29, 2024 and the fiscal year ended August 31, 2023. Fair Value Measurements as of February 29, 2024 (in thousands) Level 1 Level 2 Level 3 Total Assets Money market funds (1) $ 103,333 $ — $ — $ 103,333 Mutual funds (2) — 68,519 — 68,519 Derivative instruments (3) — 418 — 418 Total assets measured at fair value $ 103,333 $ 68,937 $ — $ 172,270 Liabilities Derivative instruments (3) $ — $ 490 $ — $ 490 Contingent Liability (4) — — 8,282 8,282 Total liabilities measured at fair value $ — $ 490 $ 8,282 $ 8,772 Fair Value Measurements as of August 31, 2023 (in thousands) Level 1 Level 2 Level 3 Total Assets Money market funds (1) $ 137,125 $ — $ — $ 137,125 Mutual funds (2) — 32,210 — 32,210 Derivative instruments (3) — 4,383 — 4,383 Total assets measured at fair value $ 137,125 $ 36,593 $ — $ 173,718 Liabilities Derivative instruments (3) $ — $ 608 $ — $ 608 Contingent Liability (4) — — 8,008 8,008 Total liabilities measured at fair value $ — $ 608 $ 8,008 $ 8,616 (1) Our money market funds are readily convertible into cash. The net asset value of each fund on the last day of the reporting period is used to determine its fair value. Our money market funds are included in Cash and cash equivalents within the Consolidated Balance Sheets. (2) Our mutual funds' fair value is based on the fair value of the underlying investments held by the mutual funds, allocated to each share of the mutual fund using a net asset value approach. The fair value of the underlying investments is based on observable inputs. Our mutual funds are included in Investments within the Consolidated Balance Sheets. (3) Our derivative instruments as of February 29, 2024 included our foreign exchange forward contracts and, as of August 31, 2023, included our foreign exchange forward contracts and our 2022 Swap Agreement. We utilize the income approach to measure fair value for our foreign exchange forward contracts. The income approach uses pricing models that rely on market observable inputs such as spot, forward and interest rates, as well as credit default swap spreads. To estimate fair value for our interest rate swap agreement, we utilize a present value of future cash flows, leveraging a model-derived valuation that uses observable inputs such as interest rate yield curves. Refer to Note 5, Derivative Instruments , for more information on our derivative instruments and their classification within the Consolidated Balance Sheets. (4) Our contingent liability resulted from the acquisition of a business during fiscal 2023. This liability reflects the present value of potential future payments that are contingent upon the achievement of certain specified milestones. The acquisition date fair value of the contingent liability was $7.9 million and was valued using a scenario-based method. This method incorporates unobservable inputs and assumptions made by management, including the probability of achieving specified milestones, expected time until payment and the discount rate. The fair value of the contingent liability is remeasured each reporting period until the contingency is resolved, with any changes in fair value recorded in Selling, general and administrative ("SG&A") within the Consolidated Statements of Income. The change in the fair value of the contingent liability from the acquisition date through February 29, 2024 was driven by the passage of time, with no changes made to key assumptions used in our fair value estimates.
Schedule of assets and liabilities measured at carrying value and fair value	The following table summarizes information on our outstanding debt as of February 29, 2024 and August 31, 2023: February 29, 2024 August 31, 2023 (in thousands) Fair Value Hierarchy Principal Amount Estimated Fair Value Principal Amount Estimated Fair Value 2027 Notes Level 1 $ 500,000 $ 465,950 $ 500,000 $ 460,890 2032 Notes Level 1 500,000 434,735 500,000 423,700 2022 Term Facility Level 3 250,000 251,093 375,000 376,406 2022 Revolving Facility Level 3 250,000 247,813 250,000 246,875 Total principal amount $ 1,500,000 $ 1,399,591 $ 1,625,000 $ 1,507,871 Total unamortized discounts and debt issuance costs (10,512) (12,300) Total net carrying value of debt $ 1,489,488 $ 1,612,700

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Feb. 29, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of gross notional values of derivative instruments	The following table summarizes the gross notional value of our foreign currency forward contracts to purchase the respective local currency with U.S. dollars as of: February 29, 2024 August 31, 2023 (in thousands) Local Currency Amount Notional Contract Amount (USD) Local Currency Amount Notional Contract Amount (USD) British Pound Sterling £ 42,400 $ 53,431 £ 45,000 $ 56,098 Indian Rupee Rs 4,391,942 52,400 Rs 3,363,150 40,300 Euro € 43,700 47,960 € 39,000 42,646 Philippine Peso ₱ 1,890,330 33,600 ₱ 1,888,541 33,600 Total $ 187,391 $ 172,644 The following is a summary of the gross notional values of our derivative instruments: (in thousands) Gross Notional Value February 29, 2024 August 31, 2023 Foreign currency forward contracts $ 187,391 $ 172,644 Interest rate swap agreement — 200,000 Total cash flow hedges $ 187,391 $ 372,644
Summary of the fair values of derivative instruments	The following is a summary of the fair values of our derivative instruments: Fair Value of Derivative Instruments (in thousands) Derivative Assets Derivative Liabilities Derivatives designated as hedging instruments Balance Sheet Classification February 29, 2024 August 31, 2023 Balance Sheet Classification February 29, 2024 August 31, 2023 Foreign currency forward contracts Prepaid expenses and other current assets $ 418 $ 1,260 Accounts payable and accrued expenses $ 490 $ 608 Interest rate swap agreement Prepaid expenses and other current assets — 3,123 Accounts payable and accrued expenses — — Total cash flow hedges $ 418 $ 4,383 $ 490 $ 608
Schedule of pre-tax effect of derivative instruments in cash flow hedging relationships	The following table provides the pre-tax effect of derivative instruments in cash flow hedging relationships for the three months ended February 29, 2024 and February 28, 2023: Gain (Loss) Recognized in AOCL on Derivatives Location of Gain (Loss) Reclassified from AOCL into Income Gain (Loss) Reclassified from AOCL into Income (in thousands) February 29, February 28, February 29, February 28, Derivatives in Cash Flow Hedging Relationships 2024 2023 2024 2023 Foreign currency forward contracts $ (623) $ (215) SG&A $ (47) $ (279) Interest rate swap agreement 17 848 Interest expense 1,046 3,945 Total cash flow hedges $ (606) $ 633 $ 999 $ 3,666 The following table provides the pre-tax effect of derivative instruments in cash flow hedging relationships for the six months ended February 29, 2024 and February 28, 2023: Gain (Loss) Reclassified in AOCL on Derivatives Location of Gain (Loss) Reclassified from AOCL into Income Gain (Loss) Reclassified from AOCL into Income (in thousands) February 29, February 28, February 29, February 28, Derivatives in Cash Flow Hedging Relationships 2024 2023 2024 2023 Foreign currency forward contracts $ (406) $ 3,108 SG&A $ 318 $ (5,244) Interest rate swap agreement 27 4,276 Interest expense 3,150 6,842 Total cash flow hedges $ (379) $ 7,384 $ 3,468 $ 1,598

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Feb. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	Changes in the carrying value of goodwill by segment for the six months ended February 29, 2024 are as follows: (in thousands) Americas EMEA Asia Pacific Total Balance at August 31, 2023 $ 704,759 $ 297,734 $ 2,243 $ 1,004,736 Acquisitions 181 — — 181 Foreign currency translations — (967) (67) (1,034) Balance at February 29, 2024 $ 704,940 $ 296,767 $ 2,176 $ 1,003,883

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Feb. 29, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of identifiable intangible assets	The following table presents the estimated useful life, gross carrying amounts and accumulated amortization totals related to our identifiable intangible assets as of February 29, 2024 and August 31, 2023: February 29, 2024 August 31, 2023 (in thousands, except useful lives) Estimated Useful Life (years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount ABA business process 36 $ 1,583,000 $ 87,944 $ 1,495,056 $ 1,583,000 $ 65,958 $ 1,517,042 Client relationships 11 to 26 265,129 74,416 190,713 265,315 68,701 196,614 Developed technology 3 to 5 145,213 45,901 99,312 109,222 45,560 63,662 Acquired databases 15 46,000 6,133 39,867 46,000 4,600 41,400 Software technology 2 to 10 142,368 112,798 29,570 142,395 108,702 33,693 Data content 7 to 20 35,169 29,320 5,849 35,021 28,508 6,513 Non-compete agreements 4 290 48 242 290 12 278 Total $ 2,217,169 $ 356,560 $ 1,860,609 $ 2,181,243 $ 322,041 $ 1,859,202
Schedule of amortization expense	The following table presents the amortization expense for our intangible assets which is included in Cost of services in our Consolidated Statements of Income: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Amortization expense $ 26,688 $ 21,782 $ 48,853 $ 43,436
Schedule of estimated intangible asset amortization expense	As of February 29, 2024, estimated intangible asset amortization expense for each of the next five years and thereafter is as follows: (in thousands) Estimated Amortization Expense Years Ended August 31, 2024 (remaining six months) $ 53,369 2025 102,958 2026 95,323 2027 72,779 2028 63,279 Thereafter 1,472,901 Total $ 1,860,609

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Feb. 29, 2024
Income Tax Disclosure [Abstract]
Schedule of income taxes and effective tax rate	The provision for income taxes and the effective tax rate are as follows: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Income before income taxes $ 168,645 $ 156,762 $ 343,841 $ 314,647 Provision for income taxes $ 27,705 $ 25,169 $ 54,346 $ 46,256 Effective tax rate 16.4 % 16.1 % 15.8 % 14.7 %

Leases (Tables)

Leases (Tables)	6 Months Ended
	Feb. 29, 2024
Leases [Abstract]
Schedule of future minimum commitments	The following table presents our future minimum lease payments and a reconciliation to the combined Current lease liabilities and Long-term lease liabilities in the Consolidated Balance Sheets as of February 29, 2024 : (in thousands) Minimum Lease Years Ended August 31, 2024 (remaining six months) $ 19,037 2025 38,022 2026 37,658 2027 36,339 2028 31,771 Thereafter 88,843 Total minimum lease payments $ 251,670 Less: Imputed interest 36,946 Total lease liabilities $ 214,724
Schedule of lease cost and other information related to leases	The following table includes components of our occupancy costs: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Operating lease costs (1) $ 7,645 $ 8,156 $ 15,263 $ 16,233 Variable lease costs (2) $ 4,817 $ 3,834 $ 9,306 $ 8,054 (1) Operating lease costs include costs associated with fixed lease payments and index-based variable payments that qualified for lease accounting under ASC 842, Leases and complied with the practical expedients and exceptions we elected. (2) Variable lease costs include costs that were not fixed at the lease commencement date and are not dependent on an index or rate. These costs were not included in the measurement of lease liabilities and primarily include variable non-lease costs, such as utilities, real estate taxes, insurance and maintenance, as well as lease costs for those leases that qualified for the short-term lease exception. The following table summarizes our weighted average remaining lease term and weighted average discount rate related to our operating leases recorded on the Consolidated Balance Sheets: As of February 29, 2024 As of August 31, 2023 Weighted average remaining lease term (in years) 7.4 7.8 Weighted average discount rate (IBR) 4.6 % 4.5 % The following table summarizes supplemental cash flow information related to our operating leases: Six Months Ended February 29, February 28, (in thousands) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities $ 19,811 $ 19,596 Lease ROU assets obtained in exchange for lease liabilities (1) $ 2,313 $ 1,379 Reductions to ROU assets resulting from reductions to lease liabilities (2) $ (23) $ — (1) Primarily includes new lease arrangements entered into during the respective period and contract modifications that extend our lease terms and/or provide additional rights. (2) Primarily relates to lease term reassessments based on contractual options to early terminate, resulting in a reduction to the lease liability and the corresponding lease ROU asset.

Debt (Tables)

Debt (Tables)	6 Months Ended
	Feb. 29, 2024
Debt Disclosure [Abstract]
Schedule of debt obligations	Our total debt obligations as of February 29, 2024 and August 31, 2023 consisted of the following: (in thousands) Issuance Date Contractual February 29, 2024 August 31, 2023 2022 Credit Agreement 2022 Term Facility 3/1/2022 3/1/2025 $ 250,000 $ 375,000 2022 Revolving Facility 3/1/2022 3/1/2027 250,000 250,000 Senior Notes 2027 Notes 3/1/2022 3/1/2027 500,000 500,000 2032 Notes 3/1/2022 3/1/2032 500,000 500,000 Total unamortized discounts and debt issuance costs (10,512) (12,300) Total Long-term debt $ 1,489,488 $ 1,612,700
Schedule of annual maturities of debt obligations	As of February 29, 2024, annual maturities on our total debt obligations, based on contractual maturity date, were as follows: (in thousands) Maturities Years Ended August 31, 2024 (remaining six months) $ — 2025 250,000 2026 — 2027 750,000 2028 — Thereafter 500,000 Total $ 1,500,000
Schedule of interest expense	The following table presents the interest expense on our outstanding debt which is a component of Interest expense in our Consolidated Statements of Income: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Interest expense on outstanding debt (1) $ 16,589 $ 16,728 $ 33,318 $ 33,256 (1) Interest expense on our outstanding debt includes the related amortization of debt issuance costs and debt discounts, net of the effects of the 2022 Swap Agreement.

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Feb. 29, 2024
Equity [Abstract]
Schedule of share repurchases	Share Repurchases Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands, except share data) 2024 2023 2024 2023 Repurchases of common stock under the share repurchase program (1) 113,050 — 249,000 — Total cost of shares repurchased (1) $ 52,255 $ — $ 112,165 $ —
Schedule of dividends declared	Our Board of Directors approved the following dividends: Year Ended Dividends per Record Date Total Amount (in thousands) Payment Date Fiscal 2024 First Quarter $ 0.98 November 30, 2023 $ 37,299 December 21, 2023 Second Quarter $ 0.98 February 29, 2024 $ 37,360 March 21, 2024 Fiscal 2023 First Quarter $ 0.89 November 30, 2022 $ 34,010 December 15, 2022 Second Quarter $ 0.89 February 28, 2023 $ 34,099 March 16, 2023
Schedule of components of AOCL	The components of AOCL as of February 29, 2024 and August 31, 2023 were as follows: (in thousands) February 29, 2024 August 31, 2023 Accumulated unrealized gains (losses) on cash flow hedges, net of tax $ 40 $ 2,880 Accumulated foreign currency translation adjustments (91,069) (90,021) Total AOCL $ (91,029) $ (87,141)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Feb. 29, 2024
Earnings Per Share [Abstract]
Schedule of earnings per share	A reconciliation of the weighted average shares outstanding used in the Basic EPS and Diluted EPS computation is as follows: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands, except per share data) 2024 2023 2024 2023 Numerator Net income used for calculating Basic EPS and Diluted EPS $ 140,940 $ 131,593 $ 289,495 $ 268,391 Denominator Weighted average common shares used in the calculation of Basic EPS 38,103 38,281 38,059 38,201 Common stock equivalents associated with stock-based compensation plan 547 700 587 746 Shares used in the calculation of Diluted EPS 38,650 38,981 38,646 38,947 Basic EPS $ 3.70 $ 3.44 $ 7.61 $ 7.03 Diluted EPS $ 3.65 $ 3.38 $ 7.49 $ 6.89
Schedule of awards excluded from diluted EPS	The following table presents those awards that were excluded from Diluted EPS for the periods presented: As of February 29, As of February 28, (in thousands) 2024 2023 Out-of-the-money stock options 0 543 PSUs 95 93

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Feb. 29, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of stock-based compensation	The following table presents the stock-based compensation for the periods presented: Three Months Ended Six Months Ended February 29, February 28, February 29, February 28, (in thousands) 2024 2023 2024 2023 Stock-based compensation expense $ 16,652 $ 15,325 $ 30,962 $ 27,500
Schedule of stock option activity	The following table presents the employee stock options granted under the LTIP for the six months ended February 29, 2024 and February 28, 2023: Six Months Ended February 29, February 28, 2024 2023 Stock options granted (1) 243,125 267,641 Weighted average exercise price $ 436.63 $ 426.25 Weighted average grant date fair value $ 132.60 $ 125.58 (1) Includes the annual employee grant on November 1, 2023 and November 1, 2022 of 242,371 and 266,051 stock options, respectively. These annual employee grants both vest 20% annually on the anniversary date of the grant and are fully vested after five years, expiring ten years from the date of grant.
Schedule of assumptions about stock options	As part of the November 1, 2023 annual employee grant, the estimated grant date fair value, using the binomial model, leveraged the following assumptions: November 1, 2023 Annual Employee Grant Details Risk-free interest rate 4.78% - 5.53% Expected life (years) 6.62 Expected volatility 23.5% Dividend yield 0.90% Estimated fair value $132.60 Exercise price $436.57
Schedule of restricted stock awards activity	Our Restricted Stock Awards granted during the six months ended February 29, 2024 and February 28, 2023, primarily related to our annual grants on November 1, 2023 and November 1, 2022, respectively, and were as follows: Six Months Ended February 29, February 28, 2024 2023 Shares Weighted Average Grant Date Fair Value Per Award Shares Weighted Average Grant Date Fair Value Per Award RSUs Granted (1) 64,827 $ 425.09 47,371 $ 415.33 PSUs Granted (2) 37,008 $ 424.63 34,482 $ 415.31 Performance adjustment - PSUs (3) 14,472 $ 306.33 8,542 $ 245.67 Total Restricted Stock Awards 116,307 90,395 (1) The majority of the RSUs granted vest 20% annually on the anniversary date of the grant and are fully vested after five years. (2) The majority of the PSUs granted cliff vest on the third anniversary of the grant date, subject to the achievement of certain performance metrics. The ultimate number of common shares that may be earned pursuant to these PSU awards range from 0% to 150% of the number of target shares for the November 2022 annual grant and 0% to 200% of the number of target shares for the November 2023 annual grant, depending on the level of our achievement of stated financial performance objectives.

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Feb. 29, 2024
Segment Reporting [Abstract]
Schedule of segment reporting information	The following tables reflect the results of operations of our segments: (in thousands) Americas EMEA Asia Pacific Total For the three months ended February 29, 2024 Revenues $ 352,618 $ 139,176 $ 54,151 $ 545,945 Operating income $ 81,711 $ 62,839 $ 37,392 $ 181,942 Capital expenditures (1) $ 20,015 $ 295 $ 1,607 $ 21,917 (in thousands) Americas EMEA Asia Pacific Total For the three months ended February 28, 2023 Revenues $ 331,121 $ 132,508 $ 51,456 $ 515,085 Operating income $ 61,181 $ 68,941 $ 39,128 $ 169,250 Capital expenditures (1) $ 15,589 $ 739 $ 1,128 $ 17,456 (in thousands) For the six months ended February 29, 2024 Americas EMEA Asia Pacific Total Revenues $ 700,985 $ 278,737 $ 108,439 $ 1,088,161 Operating income $ 162,559 $ 131,704 $ 76,719 $ 370,982 Capital expenditures (1) $ 34,793 $ 1,256 $ 2,334 $ 38,383 (in thousands) For the six months ended February 28, 2023 Americas EMEA Asia Pacific Total Revenues $ 654,488 $ 263,246 $ 102,166 $ 1,019,900 Operating income $ 128,712 $ 136,263 $ 76,170 $ 341,145 Capital expenditures (1) $ 31,343 $ 1,312 $ 2,761 $ 35,416 (1) Capital expenditures includes purchases of property, equipment and leasehold improvements and capitalized internal-use software. Segment Total Assets The following table reflects the total assets for our segments as of: (in thousands) February 29, 2024 August 31, 2023 Segment Assets Americas $ 3,121,172 $ 3,148,192 EMEA 605,954 558,393 Asia Pacific 263,740 256,337 Total assets $ 3,990,866 $ 3,962,922

Description of Business (Detail

Description of Business (Details)	6 Months Ended
	Feb. 29, 2024 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	3
Number of reportable segments	3

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	6 Months Ended
	Feb. 29, 2024	Aug. 31, 2023
Accounting Policies [Abstract]
Accounts receivable reserve	$ 10,787	$ 7,769
Data costs | Supplier Concentration Risk | Supplier One
Concentration Risk [Line Items]
Concentration risk, percentage (more than)	10%
Data costs | Supplier Concentration Risk | Supplier Two
Concentration Risk [Line Items]
Concentration risk, percentage (more than)	10%

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Disaggregation of Revenue [Line Items]
Total Revenues	$ 545,945	$ 515,085	$ 1,088,161	$ 1,019,900
Americas
Disaggregation of Revenue [Line Items]
Total Revenues	352,618	331,121	700,985	654,488
EMEA
Disaggregation of Revenue [Line Items]
Total Revenues	139,176	132,508	278,737	263,246
Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenues	$ 54,151	$ 51,456	$ 108,439	$ 102,166

Fair Value Measures - Assets an

Fair Value Measures - Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Assets
Derivative instruments	$ 418	$ 4,383
Total assets measured at fair value	172,270	173,718
Liabilities
Derivative instruments	490	608
Contingent Liability	8,282	8,008
Total liabilities measured at fair value	8,772	8,616
Series of Individually Immaterial Business Acquisitions
Liabilities
Contingent Liability		7,900
Mutual funds
Assets
Mutual funds	68,519	32,210
Money market funds
Assets
Money market funds	103,333	137,125
Level 1
Assets
Derivative instruments	0	0
Total assets measured at fair value	103,333	137,125
Liabilities
Derivative instruments	0	0
Contingent Liability	0	0
Total liabilities measured at fair value	0	0
Level 1 | Mutual funds
Assets
Mutual funds	0	0
Level 1 | Money market funds
Assets
Money market funds	103,333	137,125
Level 2
Assets
Derivative instruments	418	4,383
Total assets measured at fair value	68,937	36,593
Liabilities
Derivative instruments	490	608
Contingent Liability	0	0
Total liabilities measured at fair value	490	608
Level 2 | Mutual funds
Assets
Mutual funds	68,519	32,210
Level 2 | Money market funds
Assets
Money market funds	0	0
Level 3
Assets
Derivative instruments	0	0
Total assets measured at fair value	0	0
Liabilities
Derivative instruments	0	0
Contingent Liability	8,282	8,008
Total liabilities measured at fair value	8,282	8,008
Level 3 | Mutual funds
Assets
Mutual funds	0	0
Level 3 | Money market funds
Assets
Money market funds	$ 0	$ 0

Fair Value Measures - Carrying

Fair Value Measures - Carrying Value and Estimated Carrying Value and Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total unamortized discounts and debt issuance costs	$ (10,512)	$ (12,300)
Total net carrying value of debt	1,489,488	1,612,700
Principal Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	1,500,000	1,625,000
Principal Amount | Level 1 | Senior Notes | 2027 Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	500,000	500,000
Principal Amount | Level 1 | Senior Notes | 2032 Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	500,000	500,000
Principal Amount | Level 3 | Line of Credit | 2022 Credit Agreement | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	250,000	375,000
Principal Amount | Level 3 | Line of Credit | 2022 Credit Agreement | Revolving Credit Facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	250,000	250,000
Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	1,399,591	1,507,871
Estimated Fair Value | Level 1 | Senior Notes | 2027 Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	465,950	460,890
Estimated Fair Value | Level 1 | Senior Notes | 2032 Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	434,735	423,700
Estimated Fair Value | Level 3 | Line of Credit | 2022 Credit Agreement | Term Loan
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	251,093	376,406
Estimated Fair Value | Level 3 | Line of Credit | 2022 Credit Agreement | Revolving Credit Facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total principal amount	$ 247,813	$ 246,875

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands		6 Months Ended	9 Months Ended	21 Months Ended
	Feb. 29, 2024	Feb. 29, 2024	Feb. 28, 2025	Feb. 28, 2024	Mar. 01, 2024	Aug. 31, 2023	Mar. 01, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Estimated pre-tax derivative gains (losses) to be reclassified in next 12 months	$ (100)
Minimum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Currency exposure (as a percent)		25%
Maximum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Currency exposure (as a percent)		75%
Cash flow hedging | Designated as hedging instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount	187,391	$ 187,391				$ 372,644
Cash flow hedging | Designated as hedging instrument | Interest rate swap agreement
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount	$ 0	$ 0				$ 200,000	$ 800,000
Fixed rate (as a percent)							1.162%
Quarterly decline in notional amount				$ 100,000
Cash flow hedging | Designated as hedging instrument | Interest rate swap agreement | Forecast
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Quarterly decline in notional amount			$ 50,000
Cash flow hedging | Designated as hedging instrument | Interest rate swap agreement | Subsequent event
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount					$ 200,000
Fixed rate (as a percent)					5.145%

Derivative Instruments - Gross

Derivative Instruments - Gross Notional Values by Currency (Details) - Cash flow hedging - Designated as hedging instrument ₱ in Thousands, € in Thousands, ₨ in Thousands, £ in Thousands, $ in Thousands	Feb. 29, 2024 GBP (£)	Feb. 29, 2024 USD ($)	Feb. 29, 2024 INR (₨)	Feb. 29, 2024 EUR (€)	Feb. 29, 2024 PHP (₱)	Aug. 31, 2023 GBP (£)	Aug. 31, 2023 USD ($)	Aug. 31, 2023 INR (₨)	Aug. 31, 2023 EUR (€)	Aug. 31, 2023 PHP (₱)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount		$ 187,391					$ 372,644
Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount		187,391					172,644
British Pound Sterling
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount	£ 42,400	53,431				£ 45,000	56,098
Indian Rupee
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount		52,400	₨ 4,391,942				40,300	₨ 3,363,150
Euro
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount		47,960		€ 43,700			42,646		€ 39,000
Philippine Peso
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gross notional amount		$ 33,600			₱ 1,890,330		$ 33,600			₱ 1,888,541

Derivative Instruments - Gros_2

Derivative Instruments - Gross Notional Values (Details) - Cash flow hedging - Designated as hedging instrument - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023	Mar. 01, 2022
Derivative [Line Items]
Gross notional amount	$ 187,391	$ 372,644
Foreign currency forward contracts
Derivative [Line Items]
Gross notional amount	187,391	172,644
Interest rate swap agreement
Derivative [Line Items]
Gross notional amount	$ 0	$ 200,000	$ 800,000

Derivative Instruments - Fair V

Derivative Instruments - Fair Value Amount of Derivative Instruments (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Assets	$ 418	$ 4,383
Derivative Liabilities	490	608
Cash flow hedging | Designated as hedging instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Assets	418	4,383
Derivative Liabilities	$ 490	$ 608
Cash flow hedging | Designated as hedging instrument | Foreign currency forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Assets, location	Prepaid expenses and other current assets	Prepaid expenses and other current assets
Derivative Assets	$ 418	$ 1,260
Derivative Liabilities, location	Accounts payable and accrued expenses	Accounts payable and accrued expenses
Derivative Liabilities	$ 490	$ 608
Cash flow hedging | Designated as hedging instrument | Interest rate swap agreement
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Assets, location	Prepaid expenses and other current assets	Prepaid expenses and other current assets
Derivative Assets	$ 0	$ 3,123
Derivative Liabilities, location	Accounts payable and accrued expenses	Accounts payable and accrued expenses
Derivative Liabilities	$ 0	$ 0

Derivative Instruments - Pre-Ta

Derivative Instruments - Pre-Tax Effect of Cash Flow Hedging Relationships (Details) - Cash flow hedging - Designated as hedging instrument - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (Loss) Recognized in AOCL on Derivatives	$ (606)	$ 633	$ (379)	$ 7,384
Gain (Loss) Reclassified from AOCL into Income	999	3,666	3,468	1,598
Foreign currency forward contracts | SG&A
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (Loss) Recognized in AOCL on Derivatives	(623)	(215)	(406)	3,108
Gain (Loss) Reclassified from AOCL into Income	(47)	(279)	318	(5,244)
Interest rate swap agreement | Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (Loss) Recognized in AOCL on Derivatives	17	848	27	4,276
Gain (Loss) Reclassified from AOCL into Income	$ 1,046	$ 3,945	$ 3,150	$ 6,842

Goodwill - Changes in the Carry

Goodwill - Changes in the Carrying Amount of Goodwill by Segment (Details) $ in Thousands	6 Months Ended
	Feb. 29, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,004,736
Acquisitions	181
Foreign currency translations	(1,034)
Ending balance	1,003,883
Americas
Goodwill [Roll Forward]
Beginning balance	704,759
Acquisitions	181
Foreign currency translations	0
Ending balance	704,940
EMEA
Goodwill [Roll Forward]
Beginning balance	297,734
Acquisitions	0
Foreign currency translations	(967)
Ending balance	296,767
Asia Pacific
Goodwill [Roll Forward]
Beginning balance	2,243
Acquisitions	0
Foreign currency translations	(67)
Ending balance	$ 2,176

Goodwill - Narrative (Details)

Goodwill - Narrative (Details) - USD ($)	3 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment loss	$ 0	$ 0

Intangible Assets - Identifiabl

Intangible Assets - Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 2,217,169	$ 2,181,243
Accumulated Amortization	356,560	322,041
Total	$ 1,860,609	1,859,202
ABA business process
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	36 years
Gross Carrying Amount	$ 1,583,000	1,583,000
Accumulated Amortization	87,944	65,958
Total	1,495,056	1,517,042
Client relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	265,129	265,315
Accumulated Amortization	74,416	68,701
Total	190,713	196,614
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	145,213	109,222
Accumulated Amortization	45,901	45,560
Total	$ 99,312	63,662
Acquired databases
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	15 years
Gross Carrying Amount	$ 46,000	46,000
Accumulated Amortization	6,133	4,600
Total	39,867	41,400
Software technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	142,368	142,395
Accumulated Amortization	112,798	108,702
Total	29,570	33,693
Data content
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	35,169	35,021
Accumulated Amortization	29,320	28,508
Total	$ 5,849	6,513
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	4 years
Gross Carrying Amount	$ 290	290
Accumulated Amortization	48	12
Total	$ 242	$ 278
Minimum | Client relationships
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	11 years
Minimum | Developed technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	3 years
Minimum | Software technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	2 years
Minimum | Data content
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	7 years
Maximum | Client relationships
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	26 years
Maximum | Developed technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	5 years
Maximum | Software technology
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Maximum | Data content
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (years)	20 years

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Weighted average useful life (in years)	32 years 1 month 6 days
Impairment of intangible assets	$ 0	$ 0

Intangible Assets - Amortizatio

Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 26,688	$ 21,782	$ 48,853	$ 43,436

Intangible Assets - Estimated I

Intangible Assets - Estimated Intangible Asset Amortization Expense (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remaining six months)	$ 53,369
2025	102,958
2026	95,323
2027	72,779
2028	63,279
Thereafter	1,472,901
Total	$ 1,860,609	$ 1,859,202

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Income Tax Disclosure [Abstract]
Income before income taxes	$ 168,645	$ 156,762	$ 343,841	$ 314,647
Provision for income taxes	$ 27,705	$ 25,169	$ 54,346	$ 46,256
Effective tax rate	16.40%	16.10%	15.80%	14.70%

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Lessee, Lease, Description [Line Items]
ROU assets	$ 133,917	$ 141,837
Lease liabilities	$ 214,724
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	12 years

Leases - Future Minimum Commitm

Leases - Future Minimum Commitments (Details) $ in Thousands	Feb. 29, 2024 USD ($)
Leases [Abstract]
2024 (remaining six months)	$ 19,037
2025	38,022
2026	37,658
2027	36,339
2028	31,771
Thereafter	88,843
Total minimum lease payments	251,670
Less: Imputed interest	36,946
Total lease liabilities	$ 214,724

Leases - Lease Cost And Other I

Leases - Lease Cost And Other Information Related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023	Aug. 31, 2023
Leases [Abstract]
Operating lease costs	$ 7,645	$ 8,156	$ 15,263	$ 16,233
Variable lease costs	$ 4,817	$ 3,834	$ 9,306	8,054
Weighted average remaining lease term (in years)	7 years 4 months 24 days		7 years 4 months 24 days		7 years 9 months 18 days
Weighted average discount rate (incremental borrowing rate)	4.60%		4.60%		4.50%
Cash paid for amounts included in the measurement of lease liabilities			$ 19,811	19,596
Lease ROU assets obtained in exchange for lease liabilities			2,313	1,379
Reductions to ROU assets resulting from reductions to lease liabilities			$ (23)	$ 0

Debt - Debt Obligations (Detail

Debt - Debt Obligations (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Aug. 31, 2023
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,500,000
Total unamortized discounts and debt issuance costs	(10,512)	$ (12,300)
Total net carrying value of debt	1,489,488	1,612,700
Senior Notes | 2027 Notes
Debt Instrument [Line Items]
Long-term debt, gross	500,000	500,000
Senior Notes | 2032 Notes
Debt Instrument [Line Items]
Long-term debt, gross	500,000	500,000
Term Loan | Line of Credit | 2022 Credit Agreement
Debt Instrument [Line Items]
Long-term debt, gross	250,000	375,000
Revolving Credit Facility | Line of Credit | 2022 Credit Agreement
Debt Instrument [Line Items]
Long-term debt, gross	$ 250,000	$ 250,000

Debt - Annual Maturities of Deb

Debt - Annual Maturities of Debt Obligations (Details) $ in Thousands	Feb. 29, 2024 USD ($)
Debt Disclosure [Abstract]
2024 (remaining six months)	$ 0
2025	250,000
2026	0
2027	750,000
2028	0
Thereafter	500,000
Total net carrying value of debt	$ 1,500,000

Debt - Narrative (Details)

Debt - Narrative (Details)		3 Months Ended	6 Months Ended		21 Months Ended	24 Months Ended
	Mar. 01, 2022 USD ($)	Feb. 29, 2024 USD ($)	Feb. 29, 2024 USD ($)	Feb. 28, 2023 USD ($)	Nov. 30, 2023	Feb. 29, 2024 USD ($)	Mar. 01, 2024	Aug. 31, 2022 USD ($)
Debt Instrument [Line Items]
Repayments of debt			$ 125,000,000	$ 250,000,000
Interest rate swap agreement | Cash flow hedging | Designated as hedging instrument
Debt Instrument [Line Items]
Fixed rate (as a percent)	1.162%
Interest rate swap agreement | Cash flow hedging | Designated as hedging instrument | Subsequent event
Debt Instrument [Line Items]
Fixed rate (as a percent)							5.145%
Senior Notes
Debt Instrument [Line Items]
Debt issuance costs	$ 9,100,000
Discount	$ 2,800,000
Redemption price (as a percent)	101%
2022 Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Debt issuance costs								$ 9,500,000
Covenants, required maximum leverage ratio		3.75	3.75			3.75
2022 Credit Agreement | Line of Credit | Term SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.975%			1.10%
2022 Credit Agreement | Line of Credit | Term SOFR | Interest Rate Margin
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.875%			1%
2022 Credit Agreement | Line of Credit | Term SOFR | Credit Spread Adjustment
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.10%			0.10%
2027 Notes | Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500,000,000
Stated interest rate (as a percent)	2.90%
2032 Notes | Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 500,000,000
Stated interest rate (as a percent)	3.45%
Revolving Credit Facility | 2022 Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Lines of credit	$ 250,000,000
Maximum borrowing capacity	500,000,000
Maximum additional borrowings	750,000,000
Commitment fee percentage		0.10%			0.125%
Letter of Credit | 2022 Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity	100,000,000
Swingline Loan | 2022 Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity	50,000,000
Term Loan | 2022 Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Aggregate principal amount	$ 1,000,000,000
Repayments of debt		$ 62,500,000	$ 125,000,000			$ 750,000,000
Voluntary prepayments of debt		$ 50,000,000	$ 100,000,000			$ 662,500,000

Debt - Interest Expense (Detail

Debt - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Debt Disclosure [Abstract]
Interest expense on outstanding debt	$ 16,589	$ 16,728	$ 33,318	$ 33,256

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Feb. 29, 2024	Aug. 31, 2023	Mar. 01, 2022
Concentration Risk [Line Items]
Purchase commitment, remaining minimum amount committed		$ 362,200,000
Letters of credit outstanding	$ 500,000	600,000
Letter of Credit | 2022 Credit Agreement | Line of Credit
Concentration Risk [Line Items]
Maximum borrowing capacity			$ 100,000,000
Capital Commitment
Concentration Risk [Line Items]
Capital commitments	$ 600,000	$ 700,000

Stockholders' Equity - Share Re

Stockholders' Equity - Share Repurchases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Equity [Abstract]
Repurchases of common stock under the share repurchase program (in shares)	113,050	0	249,000	0
Total cost of shares repurchased	$ 52,255	$ 0	$ 112,165	$ 0
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining authorized repurchase amount	$ 187,800		$ 187,800
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased from employees (in shares)	1,999	1,853	32,383	27,713
Value of shares repurchased in settlement of employee tax withholding obligations	$ 1,000	$ 800	$ 14,500	$ 11,800

Stockholders' Equity - Dividend

Stockholders' Equity - Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Feb. 29, 2024	Nov. 30, 2023	Feb. 28, 2023	Nov. 30, 2022
Equity [Abstract]
Dividends per Share of Common Stock (in USD per share)	$ 0.98	$ 0.98	$ 0.89	$ 0.89
Total Amount	$ 37,360	$ 37,299	$ 34,099	$ 34,010

Stockholders' Equity - Accumula

Stockholders' Equity - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Feb. 29, 2024	Nov. 30, 2023	Aug. 31, 2023	Feb. 28, 2023	Nov. 30, 2022	Aug. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total AOCL	$ 1,801,754	$ 1,700,740	$ 1,619,930	$ 1,607,154	$ 1,474,128	$ 1,331,408
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total AOCL	(91,029)	$ (86,887)	(87,141)	$ (92,243)	$ (93,059)	$ (108,383)
Accumulated unrealized gains (losses) on cash flow hedges, net of tax
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total AOCL	40		2,880
Accumulated foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total AOCL	$ (91,069)		$ (90,021)

Earnings Per Share - Weighted A

Earnings Per Share - Weighted Average Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Numerator
Net income used for calculating Basic EPS	$ 140,940	$ 131,593	$ 289,495	$ 268,391
Net income used for calculating Diluted EPS	$ 140,940	$ 131,593	$ 289,495	$ 268,391
Denominator
Weighted average common shares used in the calculation of Basic EPS (in shares)	38,103	38,281	38,059	38,201
Common stock equivalents associated with stock-based compensation plan (in shares)	547	700	587	746
Shares used in the calculation of Diluted EPS (in shares)	38,650	38,981	38,646	38,947
Basic EPS (in USD per share)	$ 3.70	$ 3.44	$ 7.61	$ 7.03
Diluted EPS (in USD per share)	$ 3.65	$ 3.38	$ 7.49	$ 6.89

Earnings Per Share - Awards Exc

Earnings Per Share - Awards Excluded from Diluted EPS (Details) - shares shares in Thousands	6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Out-of-the-money stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	0	543
PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (in shares)	95	93

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($)			3 Months Ended		6 Months Ended
	Nov. 01, 2023	Nov. 01, 2022	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation costs capitalized			$ 0	$ 0	$ 0	$ 0
Unrecognized compensation expense related to non-vested equity			151,800,000		$ 151,800,000
Weighted average period for recognition (in years)					3 years 1 month 6 days
Stock-based compensation expense			$ 16,652,000	15,325,000	$ 30,962,000	27,500,000
Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)			3,700,000		3,700,000
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage (as a percent)	0%	0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage (as a percent)	200%	150%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Offering period (in months)					3 months
Purchase price (as a percent)					85%
Maximum employee subscription rate (as a percent)			10%		10%
Maximum contribution limit					$ 25,000
Required holding period (in months)					18 months
Stock-based compensation expense			$ 600,000	$ 600,000	$ 1,200,000	$ 1,300,000
Capital shares reserved for future issuance (in shares)			45,503		45,503

Stock-Based Compensation - Expe

Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based compensation expense	$ 16,652	$ 15,325	$ 30,962	$ 27,500

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Activity (Details) - Employee - $ / shares			6 Months Ended
	Nov. 01, 2023	Nov. 01, 2022	Feb. 29, 2024	Feb. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)	242,371	266,051	243,125	267,641
Weighted average exercise price (in USD per share)			$ 436.63	$ 426.25
Weighted average grant date fair value (in USD per share)			$ 132.60	$ 125.58
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average exercise price (in USD per share)	$ 436.57
Weighted average grant date fair value (in USD per share)	$ 132.60
Vesting (as a percent)	20%	20%
Vesting period (in years)	5 years	5 years
Expiration period (in years)	10 years	10 years

Stock-Based Compensation - Weig

Stock-Based Compensation - Weighted Average Assumptions (Details) - Employee - $ / shares		6 Months Ended
	Nov. 01, 2023	Feb. 29, 2024	Feb. 28, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated fair value (in USD per share)		$ 132.60	$ 125.58
Exercise price (in USD per share)		$ 436.63	$ 426.25
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate, minimum (as a percent)	4.78%
Risk-free interest rate, maximum (as a percent)	5.53%
Expected life (years)	6 years 7 months 13 days
Expected volatility (as a percent)	23.50%
Dividend yield (as a percent)	0.90%
Estimated fair value (in USD per share)	$ 132.60
Exercise price (in USD per share)	$ 436.57

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stick Awards Activity (Details) - $ / shares			6 Months Ended
	Nov. 01, 2023	Nov. 01, 2022	Feb. 29, 2024	Feb. 28, 2023
Restricted stock units and performance-based awards | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, total (in shares)			116,307	90,395
RSUs | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			64,827	47,371
Weighted average grant date fair value, granted (in USD per share)			$ 425.09	$ 415.33
Vesting (as a percent)	20%	20%
Vesting period (in years)	5 years	5 years
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage (as a percent)	0%	0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage (as a percent)	200%	150%
PSUs | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			37,008	34,482
Granted for performance adjustment (in shares)			14,472	8,542
Weighted average grant date fair value, granted (in USD per share)			$ 424.63	$ 415.31
Weighted average grant date fair value, granted for performance adjustment (in USD per share)			$ 306.33	$ 245.67

Segment Information - Narrative

Segment Information - Narrative (Details)	6 Months Ended
	Feb. 29, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	3
Number of operating segments	3

Segment Information - Results o

Segment Information - Results of Operations and Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023	Aug. 31, 2023
Revenues	$ 545,945	$ 515,085	$ 1,088,161	$ 1,019,900
Operating income	181,942	169,250	370,982	341,145
Capital expenditures	21,917	17,456	38,383	35,416
Assets	3,990,866		3,990,866		$ 3,962,922
Americas
Revenues	352,618	331,121	700,985	654,488
Operating income	81,711	61,181	162,559	128,712
Capital expenditures	20,015	15,589	34,793	31,343
Assets	3,121,172		3,121,172		3,148,192
EMEA
Revenues	139,176	132,508	278,737	263,246
Operating income	62,839	68,941	131,704	136,263
Capital expenditures	295	739	1,256	1,312
Assets	605,954		605,954		558,393
Asia Pacific
Revenues	54,151	51,456	108,439	102,166
Operating income	37,392	39,128	76,719	76,170
Capital expenditures	1,607	$ 1,128	2,334	$ 2,761
Assets	$ 263,740		$ 263,740		$ 256,337